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 ABSTRACT 
Examining the Ligand-Induced Change in Cell Adhesion using the Quartz Crystal 
Microbalance with Dissipation Monitoring 
Marcela Del Pilar Garcia 
Prof. Reinhard Schweitzer-Stenner 
Prof. Jun Xi 
 
Cell adhesion is a highly regulated process involving initial receptor-ligand binding, and 
subsequent clustering of these receptors and rapid association with the actin cytoskeleton 
as focal adhesions is assembled.  Focal adhesions enhance adhesion, working as 
structural links between the cytoskeleton and the extracellular matrix, to finally trigger 
signaling pathways that direct cell function.  In the past two decades, the quartz crystal 
microbalance (QCM) has become a powerful bio-analytical tool that is capable of 
studying complex biological processes such as cell adhesion.  The work presented 
investigates the use of the quartz crystal microbalance with dissipation monitoring 
(QCM-D) to track ligand-induced changes in cell adhesion of a monolayer of cells by 
means of real-time changes in energy dissipation factor, ∆D, of the cells.  Here I report 
the first QCM-D study that examines the restructuring of focal adhesions induced by the 
epidermal growth factor (EGF) in MCF-10A cells.  The epidermal growth factor receptor 
(EGFR) plays a major role in cell migration and invasion and is considered to be the 
primary source of activation of various malignant tumors. Cells that overexpress wildtype 
EGFR (termed MCF-10A-EGFR cells) displayed a different kinetic profile from the 
MCF-10A cells that had a lower level of EGFR.  MCF-10A-EGFR cells had a higher rate 
for the initial disassembly of focal adhesion and a much lower rate for the alter 
reassembly of focal adhesions.  These results suggest that the effects displayed by EGFR-
overexpressing cells may contribute to the initiation and maintenance of a more favorable 
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adhesion state for cell migration.  Additionally, I report a complex de-adhesion process, 
which can be altered by inhibitors of signaling pathways and cytoskeleton formation in a 
dose-dependent manner.  The IC50 values attained from the dose dependencies are in 
strong agreement with the values reported in the literature.  These results also 
demonstrated a quantitative relationship between the time-dependent ΔD-response and 
the levels of focal adhesions.  Furthermore, I report a novel application of QCM-D for the 
detection of EGCG-induced ROS formation.  The results from this study showed that 
EGCG-induced ∆D-response can be correlated with the change of EGCG-induced ROS 
formation.  The QCM-D is a highly sensitive, non-invasive, and label-free technique that 
has a broad range of applications in the fundamental study of cellular processes, such as 
cell signaling and trafficking and mechanotransduction and holds promise to become an 
effective sensing platform for screening therapeutic agents and ROS formation.   
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Chapter 1:  Introduction to cell adhesion 
Cancer cells have a wide variety of migration and invasion mechanisms
1
.  These 
mechanisms allow cancer cells to enter the blood or lymphatic vessels where they can 
spread to other organs and then undergo metastatic growth
1-2
.  In order to spread to other 
tissues, cancer cells use mechanisms that are identical to those used by normal cells, 
during various physiological events, such as wound healing and embryonic 
development
3
.  Tumor cell invasion and metastasis are the main characteristics of 
advanced stage cancer and are usually associated with poor patient prognosis
3-5
.  Tumor 
cell invasion is highly complex and requires the coordination of a multitude of processes, 
including cell adhesion, motility, and proteolysis
5-7
.  Being able to understand not only 
the molecular basis of malignant transformation but also the differences between 
malignant and noncancerous cells could contribute to the development of methods to 
interfere with these events in cancerous cells.    
The epidermal growth factor receptor (EGFR) is a cell-surface receptor
8-10
, which 
regulates cell growth, proliferation, motility and differentiation through its downstream 
signaling pathways
11-12
.  Overexpression of EGFR is one of the mechanisms that can 
interfere with the regulation of these signaling pathways and lead to the development of 
cancer cells
13
, among other mechanisms.  In fact, overexpression of EGFR is widely 
reported in a variety of tumor cell lines (bladder, cervical, breast, gastric, ovarian, head 
and neck cancers) and has been associated with poor prognosis and decreased patient 
survival
9, 14-20
.  Understanding the processes in which enhanced tumor cell migration, 
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invasion, metastasis and angiogenesis work can contribute to a more effective cancer 
diagnosis, treatment and prognosis
21
. 
Some of the conventional methods to study cellular responses to EGFR signaling 
include the use of fluorescent labels to track the location, trafficking and organization of 
the particular signaling molecule being studied
22-24
.  Although these methods have been 
successful in identifying some of the main activators, effectors, enzymes and substrates 
present in EGFR signaling, they fail to reveal dynamic details of the cellular response in a 
native environment.  These approaches are limited in providing more information on the 
functional response of the whole cell; this is due to the complexity of the signaling 
network and intracellular dynamics.  The incorporation of fluorescent labels tends to 
create a non-native and physiologically irrelevant cellular environment, which could 
potentially lead to ambiguous results.  In addition, the temporal resolution of these label-
based approaches is not high, thus limiting the amount of information obtained from the 
dynamics of cell signaling.    
All of these problems can be avoided with the use of label-free sensor 
technologies like the quartz crystal microbalance with dissipation monitoring (QCM-D).  
This type of technology can provide integrated and phenotypic readout at the whole cell 
level.  Most label-free sensors are non-invasive and capable of real-time measurements of 
cell signaling with high temporal resolution and sensitivity.  The application of label-free 
sensors in areas of cell biology, such as cell adhesion, cell barrier functions, cell signaling 
and viral infection, have been steadily increasing
25-31
.          
This chapter will introduce the basic concepts of the cell adhesion process, paying 
attention to signaling pathways that mediate cell adhesion, in particular EGFR 
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downstream signaling pathways.  It will also describe some of the common methods to 
detect cellular responses and how the use of QCM-D can circumvent the problems that 
arise with the use of end-point detection methods.   All of these points are important for 
understanding the material that is presented in this thesis.   
This work is significant because it provides a novel approach to effectively use 
QCM-D as a sensing platform for screening cell signaling pathways by using 
pharmacological intervention that can either stimulate or inhibit a specific signaling 
pathway.  These studies add an important dimension to our existing knowledge of the 
role that signaling pathways have on the dynamics, regulation and function of adhesion 
complexes.     In addition, the results from the studies presented here will deliver a new 
context for understanding the role of signaling pathways in various physiological and 
pathological processes.  
1.1 Cell adhesion 
Cell adhesion is an essential biological process for cell survival, differentiation, 
migration, and differentiation during embryonic development, wound healing and 
tumorigenesis
32-33
.  There are two types of cell adhesion: cell-substrate and cell-cell 
adhesion
34-36
.  Cell-substrate adhesion is the main cell adhesion type, and it is mediated 
through a class of receptors known as integrins
34, 37
.  Cell-cell adhesion refers to the 
contact formed between neighboring cells; this process occurs through adherens 
junctions, tight junctions and gap junctions
37
.  Cell-cell adhesion plays an important role 
in the regulation of several cellular processes, such as migration, growth and 
differentiation, cell morphogenesis and wound healing
38
.  Many of the cell-cell adhesion 
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junctions are located away from the surface of the substrate; they do not interact directly 
with the substrate.  However, cell-cell adhesion has been found to be influenced by cell-
substrate adhesion
39
.    This thesis work will focus mainly on the process of cell-substrate 
adhesion. 
 
Figure 1.1:  The process of cell adhesion.  In step 1, the cell comes into contact with the cell substrate and loosely 
attaches to the surface.  In step 2, the cell begins to flatten and spread its membrane over the substrate surface.  In step 
3, the cell organizes its actin filaments and forms stress fibers.  As the stress fibers are established, the formation of 
focal adhesion (FA) takes place.       
  
The process of cell adhesion includes three steps:  cell attachment, cell spreading, 
and simultaneous organization of the actin cytoskeleton and formation of focal 
adhesion
40
.  In the first step, the cell comes into contact with the cell substrate and then 
loosely attaches to the surface, this step takes a few minutes.  In the second step, cell 
spreading, the cells begins to flatten and spread its membrane over the substrate surface 
Finally, in the last step, the cell arranges its actin filaments and forms stress fibers
41
 
(Figure 1.1).  Once these stress fibers are established, focal adhesions are formed and 
they help to anchor the cells onto the substrate
33, 42
.     
1.1.1 Integrins   
Integrins are the main cellular receptors for the extracellular matrix (ECM)
43-44
.  
Integrins are also signal transduction receptors, communicating information about 
adhesive ligands to control cell growth and structure
43-44
.  Integrins belong to a large 
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family of cell surface proteins involved in interactions with the ECM. They form several 
types of adhesion complexes, among which are focal adhesions that are found on the 
bottom surface of cells.  Focal adhesions are responsible for cell adhesion to the ECM 
and the substratum
44-46
.        
Integrins are heterodimers of two transmembrane polypeptides called α- and β- 
subunits, both of which contribute to ligand-binding specificity
47-48
.  These subunits are 
synthesized and associated into heterodimers in the endoplasmic reticulum and are 
transferred to the golgi apparatus for further carbohydrate modifications before they are 
sent to the cell surface
48.  There are eighteen α- and eight β-subunits.  These subunits can 
combine to form at least 24 different kinds of dimers, each with different ligand-binding 
specificity
48
.  The subunits are made out of large extracellular domains, single-pass 
transmembrane (TM) domains that pass through the membrane as α-helices and short 
cytoplasmic tails.  The type of combinations expressed can dictate integrin ligand-binding 
properties and can also vary among cell type
49
.  
The cytoplasmic domains of both α- and β-subunits are short, usually around 10 
to 70 amino acids long
49
.  These cytoplasmic tails of integrins interact with a large variety 
of signaling and structural proteins at focal contacts
50
.  Focal contacts or focal adhesions 
are specialized sites where integrins cluster together to transduce membrane signals and 
link actin filaments to the ECM
51
.  There are two adapter proteins, talin and vinculin, that 
link the cytoplasmic domains of β-integrins to actin filaments at the ends of stress 
fibers
51
.  Another protein, paxillin, links integrins to signaling proteins to form a 
framework for focal adhesion kinases and Src family tyrosine kinases
52
.  When integrins 
bind to ECM ligands, this process initiates signals that can modify cellular adhesion, 
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locomotion and gene expression.  The responses observed depend on the particular 
integrin and cell
51-52
.     
 Once bound, integrins cluster together and generate linkages to the actin 
cytoskeleton mediated by focal adhesions (FA)
53
.  FAs are long, streak-like structures, 
usually around 3-10 µm in length, and they are located near the periphery of the cell.  
FAs mediate strong adhesion to the ECM by controlling force transfer between integrins 
and the actin cytoskeleton
54
.  FAs also control several functions, some of which include 
differentiation, proliferation and apoptosis
55
.  What is more interesting about these 
structures is that FAs are not rigid or static, they are dynamic units that have the ability to 
assemble or disassemble in response to any chemical or mechanical stimuli
55
.   
Integrins not only provide a physical link between the inside and outside of the 
cell, they also mediate bi-directional signal transduction
56
.  They can sense changes 
inside the cellular environment and are able to produce changes in their affinity for ECM 
ligands.  Also, in response to extracellular cues, integrins have the ability to undergo 
dynamic restructuring that is mediated by several signaling pathways to effect cell 
adhesion needed for the particular cellular functions needed
57
.  Integrin binding to ECM 
ligands (i.e., fibronectin, collagen, and vitronectin) initiates signals that can modify 
cellular adhesion, locomotion, and gene expression
58
.  Through interactions with integrin 
tails, focal adhesion proteins regulate integrin activation, binding to the ECM and 
integrin-mediated signaling cascades
58
.  Furthermore, these focal adhesion proteins can 
initiate and respond to extracellular cues that control the physical properties of the 
extracellular matrix
56, 58
.   The responses observed depend upon the specific integrin and 
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cell, but include signal transduction events, such as tyrosine phosphorylation, cellular pH 
elevation, and activation of the MAPK (mitogen-activated protein kinase) cascade
59
.   
1.1.2 Integrins and Cell-Matrix Interactions 
The joining between the cell and the ECM help the cell withstand pulling forces 
without the cell being ripped out of the ECM
60
.  Integrins lack intrinsic catalytic activity, 
but they can interact directly with receptor tyrosine kinases (RTKs), such as epidermal 
growth factor receptor (EGFR), receptor tyrosine-protein kinase ERB-B2, and vascular 
endothelial growth factor receptor (VEGFR), to mediate cell adhesion, attachment, 
migration, movement, or death
61-63
.  The attachment of the cell takes place by means of 
formation of cell adhesion complexes, which are made out of integrins and several 
cytoplasmic proteins, such as talin, vinculin, paxallin, and α-actinin64-65.  All of these 
proteins act by regulating kinases, such as focal adhesion kinases (FAK) and proto-
oncogene tyrosine-protein Src kinase.  FAKs are signaling proteins that affect cell 
adhesion and spreading through modulation of cell-substrate adhesion.  The 
phosphorylation and activation of FAKs, which is a direct result of integrin activation, 
clustering and acting polymerization, is an important step for cell adhesion, spreading and 
migration
66-67
.   
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Figure 1.2:  The signaling mechanism between integrins and cytoskeleton assembly. 
 
Integrins provide a bi-directional channel for mechanochemical information 
across the cell membrane, thus providing an important mechanism for connecting the 
intracellular and extracellular compartments
68
.  Cell adhesion to the ECM transfers 
information via integrin receptors that regulate intracellular signaling
69
.  On the other 
hand, intracellular signals can induce changes in integrin conformation and activation that 
can modify its ligand-binding activity
59
.   
Integrin clustering follows the engagement of integrins with the ECM, and it 
stimulates the localized intracellular concentration of signaling molecules (Figure 1.2).  
The clustering of integrin receptors in turn activates non-receptor tyrosine kinases, such 
as FAK leading to an increase in the levels of tyrosine-phosphorylated proteins
70
.  
Serine/threonine kinases, lipid kinases, such as PI 3-kinase, and phosphatases, such as 
RPTP-α, are also regulated by integrin engagement and clustering58, 71-72.  All of these 
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kinase and phosphatase signaling pathways can induce post-translation modifications 
regulating the protein interactions and/or enzymatic activity of the ECM.                    
1.1.3 Focal adhesion associated proteins 
As stated previously, the focal adhesion is a structural unit that directs the flow of 
information from outside the cell to the inside.  The cell then processes the information 
transferred by the focal adhesion and the cell reacts accordingly.  Some of the most 
important proteins involved in the focal adhesion’s structural and signaling abilities are 
described in this section. 
α-actinin is part of a diverse group of  cytoskeletal proteins, and it is necessary for 
the attachment of actin filaments
73-74.  α-actinin can crosslink actin as well as bind to the 
cytoplasmic domain of the linker proteins zyxin and vinculin.  Paxillin and tensin are 
downstream components of FAK signaling.  Both proteins are found at actin-membrane 
attachment sites
75
.  Very little information is known of the role of tensin in focal 
adhesion; conversely, paxillin has been more investigated.  The main function of paxillin 
in focal adhesion is to act as an adaptor, recruiting signaling components at the 
cytoskeletal-membrane interface, used in events such as cell migration
76-77
.  Another 
protein, talin is one of several proteins attaching acting filaments to the integrins.  Some 
studies have shown that by inhibiting the expression of talin, cells exhibit slower 
spreading
78
, thus indicating that talin plays an important role in cell adhesion.
79
  Talin 
appears to serve as a linker of the actin cytoskeleton to the cytosplasmic domain of the 
integrins
80
.  Another important property of talin is that it can bind to vinculin, therefore 
establishing its relevance in stabilizing adhesions
79
.  Vinculin is a linker protein that is 
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tightly associated with focal adhesions; it is also present in adherens type cell-cell 
junctions and many other cell types
81
.  One of the main functions of vinculin is to attach 
actin to the plasma membrane; this process can be possible because vinculin can interact 
with various linker proteins involved in binding interactions
82
.  Besides being able to bind 
to talin, vinculin can also bind to talin, α-actinin, paxillin, actin, and the cell membrane83-
84
.  The structure of vinculin is a head-tail conformation, made up of 1066 amino acids, 
which make up a 116kD cytoskeletal protein
85
.  This structure is of importance because it 
allows vinculin to have multiple protein-binding sites
85
.  These sites are hidden when the 
protein is in its curled conformation; it is only when the tail extends that binding domains 
for other linker proteins become exposed
86-87
.  Zyxin is another linker protein, but is 
scarce in comparison to other linker proteins.  Zyxin has been proposed as a molecular 
scaffold that facilitates the assembly of functional complexes between actin and 
membrane at the spatial location of the actin-membrane interactions take place
88-89
.   
1.2 Signal transduction    
One of the most important aspects of integrin function is its ability to regulate or 
modulate signaling cascades initiated by other receptors.  Integrin-mediated cell 
anchorage has significant effects on signaling processes that are related to receptor 
tyrosine kinases, G protein-coupled receptors, and cytokine receptors
90-92
.  The coupling 
between integrins and signaling receptors permits cells to integrate positional information 
related to cell-cell or cell-substrate contacts, with information regarding the availability 
of growth or differentiation factors
93
.   
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Cells adhere to surfaces by attaching to the ECM or to neighboring cells.  The cells 
spread out and their shape contributes to their phenotypic behavior
94
.  The ECM has the 
ability to influence major cellular processes, such as growth, differentiation and 
apoptosis
95
.  Cells recognize and react to the ECM by means of integrin activation of 
intracellular signaling
68
.  Integrins play a significant role in cell signaling by monitoring 
cell signaling pathways of transmembrane protein kinases, such as receptor tyrosine 
kinases (RTK)
96
.  Integrins transduce signals to the cytoskeleton by associating with the 
proteins of the focal adhesions, e.g., talin, paxillin and vinculin.  In the past, the 
interaction between integrin and RTKs was thought to be unidirectional, but recent 
studies have shown that integrins have complex roles in cell signaling
45, 97
.  Integrins can 
regulate various protein tyrosine kinases that catalyze the phosphorylation of different 
intracellular proteins.  For example, paxillin connects the ERK/MAPK and FAK 
pathways.   ERK/MAPK binding by paxillin requires phosphorylation of Y118 on 
paxillin by Src.  Activated ERK/MAPK phosphorylates paxillin at S83, which in turn 
promotes the binding of focal adhesion kinases (FAK) to paxillin.  This results in the 
extension of lamellipodia.  FAK also causes the dissolution of focal adhesions, thereby 
coordinating detachment from the substrate with initiation of cell movement
98-100
.   
Focal adhesions have high levels of tyrosine-phosphorylated proteins, which show 
their importance as signaling molecules
101
.  The formation of focal adhesions is 
accompanied by tyrosine phosphorylation of FAK, paxillin and tensin
102-103
.  When 
tyrosine kinases are not working properly, assembly of focal adhesion is prevented and 
normal phosphotyrosine turnover prevents inhibition
54, 101
.  As a result, there is an 
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increase in the number and size of focal adhesions, indicating that tyrosine 
phosphorylation is important even in focal adhesion formation
104
.   
1.3 EGF and EGFR in cell adhesion 
EGFR is the most thoroughly studied member of the ErbB class of receptor 
tyrosine kinases
12
.  EGFR is one of four transmembrane growth factor receptor proteins 
that share similarities in structure and functions.  This group of receptor proteins includes 
the c-erbB family of receptor tyrosine kinases
105
.  EGFR is also known as HER-1 or c-
erbB-1.  EGFR is a 170 KDa glycoprotein that consists of a ligand-binding extracellular 
domain made out of four subdomains, a short transmembrane domain, and a cytoplasmic 
region consisting of a small juxtamemebrane region, a tyrosine kinase function domain, 
and a C-terminal regulatory domain.  The other members of the c-erbB group include 
HER-2, HER-3 and HER-4
105-106
.   
 Multiple ligands bind to and activate EGFR, including EGF, transforming growth 
factor-α, amphiregulin, heparin-binding EGF and betacellulin107-108.  EGF is considered 
to be one of the most important ligands for EGFR
109
.  It is a 6 KDa, 53-amino acid 
polypeptide derived from proteolytic cleavage of a transmembrane precursor and 
stabilized by three disulfide bonds.  Ligand-binding to EGFR results in receptor homo- or 
heterodimerization at the cell surface, followed by internalization of the dimerized 
receptor. After dimerization, internalization and autophosphorylation of the 
intracytoplasmic EGFR tyrosine kinase domains occurs.  The newly formed 
phosphorylated tyrosine kinase residues act as binding sites for the recruitment of signal 
transducers and activators of intracellular substrates
110
.  
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EGFR is expressed in normal cell types and its overexpression in cancer tumors 
correlates to poor patient prognosis and survival.
21, 105
  In normal cells, the expression of 
EGFR ranges from 40,000 to 100,000 receptors per cell
111
.  In contrast, EGFR is 
overexpressed in the majority of solid tumors, for example in breast cancer; EGFR may 
be expressed up to 2 x 10
6
 receptors per cell
112
.  This overexpression has shown to 
produce signal generation and activation of downstream signaling pathways, thus 
resulting in cells that have more aggressive growth and invasiveness characteristics
112
.  
The invasiveness observed is related to the fact that EGF-induced activation of EGFR 
also increases motility in various cell lines
113
.   
Activated EGFR recruits and phosphorylates various signaling molecules, such as 
phospholipase Cγ (PLC-γ), Ras and phosphatidylinositol 3-kinase (PI-3K).  The 
intracellular downstream signaling pathways leading to EGF-induced cell motility are 
Ras-Raf-MAPK, PI3K and the PLC.  The downstream signaling pathways initiated by 
activation of EGFR have various effects on cancer cells, enabling them to grow and 
spread.  For example, the PI3K signaling pathway promotes cell cycle progression and 
cellular survival
114
, and the ERK/MAPK kinase pathway leads to increase tumor cell 
proliferation
114-115
.  Additional effects of dysregulated EGFR signaling include tumor 
angiogenesis, cellular invasion, and metastasis
21, 107, 116-117
.    
1.3.1 Phospholipase C gamma1 (PLCγ1) 
There are several cellular mechanisms that are associated with tumor invasion and 
metastasis, including recognition of the ECM, and tumor cell migration.  Among these, 
tumor cell migration is promoted by EGFR signaling and subsequent activation of 
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PLCγ118.  PLCγ is required for cell motility induced by growth factors like EGF119.  This 
has been shown in several cell types including fibroblasts, keratinocytes, glial cells and 
carcinoma cells
118, 120
.  Remarkably, cell motility due to adhesion receptors, such as 
integrins appears not to require active PLC signaling, regardless of complexing together 
in focal adhesions
121
.  This contradiction of motility signaling may be critical during 
tumor progression since upregulated autocrine signaling through growth factor receptors 
is a hallmark of the invasive state of cancerous cells
120, 122
.      
Studies have shown that EGF also has effects on different aspects of cell migration.  
For example, EGFR activation of PLCγ leads to actin cytoskeleton alterations, which in 
turn enables lamellipodial extension and membrane ruffling
121, 123
. 
1.3.2 Mitogen-activated protein kinase (MAPK) 
MAPK contributes to growth factor-induced motility of tumor cells
124
.  The level 
and the duration of MAPK activation, partly influenced by the level of EGFR expression, 
seem to determine the association of MAPK in both early and late stages of cell 
migration.  MAPK interacts with the cytoskeletal machinery by phosphorylating the 
myosin light chain kinase, which in turn phosphorylates myosin light chains to generate 
the force needed to move the cell forward
125-126
. 
The MAPK/ERK signaling pathway is responsible for the EGF-induced de-
adhesion in fibroblasts through the disassembly of focal adhesions
123
, a process that 
involves the cleavage of focal adhesion with the ERK-activated cellular protease, 
calpain
127
.        
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1.3.3 Phosphoinositide 3-kinase (PI3K) 
PI3K signaling pathway regulates fundamental cellular functions, such as 
transcription, translation, proliferation, growth and survival
128-129
.  The serine/threonine 
kinase Akt/PKB is a significant kinase in this pathway.  Malfunction of this pathway has 
been associated with the development and progression of cancer
129-130
. In fact, several 
studies have shown that PI3K-Akt signaling pathway is often disrupted in human 
cancer
128
.  The development and progression of cancerous cells are the result of a 
disruption in the balance between cell proliferation and survival.   PI3K-Akt signaling is 
often associated with both cellular events and as a result, it plays a major role in tumor 
growth as well as a possible way to treat cancer
131-132
. 
The PI3K pathway is responsible for activating EGF-induced cell de-adhesion, 
this occurs through its downstream effectors, including GTPase Rho A, and/or through 
crosstalk with the MAPK/ERK pathway
133
.     
1.4 Current methods to examine cell adhesion 
Currently, there are several methods to study cell adhesion.  Some methods are 
invasive in nature and only provide an endpoint analysis, while there are other methods 
that provide non-invasive approaches and are capable of recording the different steps of 
cell-surface interaction with a reasonable time-resolution.  This section will describe both 
types of methods, mainly focusing on the non-invasive approaches to study cell adhesion.  
Non-invasive refers to approaches that eliminate the need for tags, dyes or specialized 
reagents, and insertion of foreign objects into the cells.  A non-invasive approach enables 
the use of native cells for greater biological relevance.    
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There are various approaches that have been used in the past to evaluate cell 
adhesion.  For example, in cell proliferation studies, the number of cells adhered to a 
surface is quantified by cell counting using a microscope
134
.  These measurements are 
repeated and taken several times to achieve good results.  Another low-tech method used 
to quantify the number of cells adhering to a surface is photometry, where the membrane 
permeable dyes are used for cell staining or biochemical assays.  The colorimetric MTT 
assay is a well-established method for studying cell-substrate compatibility.  This method 
is based on the intracellular reduction of a colorless tetrazolium salt to colored formazan, 
which only takes place in metabolically active cells with enough reducing agents, flavin 
adenine dinucleotide (FADH2) and nicotinamide adenine dinucleotide (NADH).  The 
amount of colored formazan is proportional to the number of vital cells and can be 
quantified by photometry
135
.  
High-tech methods commonly used include high-resolution microscopic techniques 
that have the ability to image cell morphology in contact with a surface.  Two known 
techniques are scanning force microscopy (SFM) or scanning electron microscopy 
(SEM).  Both approaches give detailed images of the upper cell surface with high spatial 
resolution.  There are other microscopic approaches that can be used to image the cells on 
the surface using different resolutions and contrast
136-137
.   
 The main disadvantage of the aforementioned methods is that they do not have 
direct access to the interface between the lower cell membrane and the substrate that the 
cell is adhered to.  This becomes a problem when studying cell-substrate interactions 
because most of the processes important for cell adhesion, spreading or migration occur 
at the interface between the cell and the surface.  Thus, techniques that can examine the 
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events that occur at that particular location would be very useful for studying all aspects 
of cell-substrate adhesion. 
In the following sections, we will describe some of the most recent methods used to 
study cell-surface interactions.  Most of the techniques that will be described are non-
invasive in nature and they are based on optical, mechanical, or acoustical principles.   
1.4.1 Optical methods  
There are a couple of optical methods used to study cell-substrate interactions.  The ones 
that will be described in this section are reflection interference contrast microscopy 
(RICM), fluorescence interference contrast microscopy (FLIC), and total internal 
reflection fluorescence microscopy (TIRF). 
Reflection interference contrast microscopy (RICM) is an optical microscopy 
technique that uses polarized light to form an image of a cell on a transparent surface
138
.  
The intensity of the signal attained is a measure of proximity of the object to the glass 
surface.  This technique is used to study events at the cell-surface without the use of 
fluorescent dyes.  In RICM the cells are usually grown on a glass coverslip, which is then 
placed under an inverted microscope and light of a specific wavelength is passed through 
a polarizer.  This polarized light is then reflected by a beam splitter towards the objective, 
which focuses the light on the specimen.  The glass surface is reflective to a certain 
degree and to reflect the polarized light.  Now, the light that is not reflected by the glass 
will travel into the cell and be reflected by the cell membrane; instead the RICM image 
results from the light that is reflected at interfaces between media of different refractive 
indices.  As a result, the intensity of the reflected light depends on the difference in the 
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refractive indices of the two adjacent media, since the difference of the glass/liquid 
interface is more significant than any other interfaces of the sample; the reflection is 
relative strong, and thus causing cell-free areas (no cells attach to the substrate) of the 
sample to appear brighter in RICM images. In cell-covered areas, the incident light that 
goes through the glass/liquid interface is reflected at the liquid/cell membrane interface.  
Due to the closeness of both interfaces, the light that is reflected depends on the optical 
path difference of the two reflected light beams
138-140
.       
RICM also provides information about dynamic processes such as cell motility, 
due to its non-invasive nature.  However, it is very complicated to extract absolute 
distances between the cell membrane and the surface using this technique because it is 
hard to measure with high precision the refractive indices of the different layers of the 
samples
139
.   
1.4.1.1 Fluorescence interference contrast microscopy 
Another optical technique used to study cellular-surface interaction is the 
fluorescence interference contrast microscopy (FLIC)
141
.  The use of this technique 
permits the quantitation of the exact cell-substrate separation distance.  The way it works 
is by growing cells on silicon substrates.   A silicon wafer is used as the reflective surface 
in FLIC.  This silicon wafer is made from silicon dioxide and it has at least four different 
height ranges, which are between 20 and 200nm.  Once the cells have attached and 
spread on the silicon substrate, the cell membranes are stained with a fluorescent dye and 
the sample is studied in an upright fluorescence microscope.  The intensity of the 
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fluorescence emitted by the fluorophore present in the substrate is modulated by the 
silicon wafer interface, which behaves like a mirror
142
.    
The intensity of the fluorescent light excitation is dependent on the distance 
between the cell membrane and silicon.  The light that is emitted by the fluorophore after 
excitation is collected from the objective lens of the microscope either directly or after 
reflection at the silicon interface.  The intensity of fluorophore excitation and the 
intensity of the fluorescence light are a function of the cell-substrate separation distance.  
It is important to note that FLIC is not a label-free method and the cells tend to 
experience phototoxicity when various experiments are done to study the dynamic 
processes at the cell-surface interface
141-142
.    
1.4.1.2 Total internal reflection fluorescence microscopy 
Total internal reflection fluorescence microscopy (TIRF) is another type of 
microscopic technique used to visualize the cell-surface interface of cells as long as they 
are grown in a transparent surface
143-144
.  Similarly to FLIC, the cell membrane requires 
fluorescent labeling.  The cells under investigation are grown on a transparent surface 
that is then illuminated from below with a laser beam.  The laser beam is aligned so it 
goes through the glass/liquid interface at an angle that is greater than or equal to the 
critical angle of total internal reflection,  crit
145
.  When the incident is totally internally 
reflected at the glass-water interface, an electromagnetic field is generated that is normal 
to the interface and that penetrates the water phase.  This field is able to excite 
fluorophores attached to the cell.  The field is termed evanescent because it decays 
exponentially with distance from the interface
146
.    
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1.4.2 Mechanical methods 
Other methods used to study cell adhesion are mechanical methods, commonly 
known as detachment assays.  In these types of assays, the substrate-anchored cells are 
exposed to mechanical forces that help to detach the cells from the surface.  The more 
mechanical stress the cells can take without detachment, the more stable the cell-surface 
interactions are.  One of the easiest ways to study cell adhesion strength is by seeding the 
cells on the surface of interest, then after a pre-set incubation time, the cells are rinsed 
with a physiological buffer.  This will cause the weakly adhered cells to detach from the 
surface.  The number of cells that remain attached to the surface is counted and the result 
is what serves as a measure for the adhesive interactions between the surface and the cells 
that are being examined.  One of the main disadvantages of this type of method is that the 
information acquired about the mechanical stability of the cell-substrate interactions is 
not sufficient.  The applied shear forces are not well-defined and they are difficult to 
control, which makes them of limited use.  This is why better methods that use well-
defined shear forces have been developed, some of these assays include centrifugation 
and hydrodynamic shear force assays
147-150
.   
1.4.2.1  Centrifugation assay 
This type of assay applies the shear forces needed to examine the stability of cell 
adhesion by centrifugation.  Once the cells have attached to the surface under study, the 
cell covered surface is placed into centrifuge tubes filled with culture medium; they are 
then centrifuged at a set angular velocity.  The centrifugal force acts as a well-defined 
shear force parallel to the surface, thus creating a mechanical pull on the cell bodies.  
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After centrifugation takes place, the cells that remain attached to the surface are counted.  
Several runs with increasing angular velocity provide the critical shear force that defines 
the mechanical stability of the cell-surface interactions.  A criterion commonly used to 
describe the strength of cell-surface interaction is the centrifugal force necessary to 
remove 50% of the initial cell population.  This method is low-throughput because only 
one set force is used per experiment
151-152
.   
1.4.2.2 Hydrodynamic flow experiment 
The hydrodynamic flow method involves placing the cell-covered surface in a 
laminar flow channel.  The adhered cells are challenged with increasing flow velocities of 
the fluid.  Similar to the centrifugation assay, the flow of the liquid generates mechanical 
forces on the cell body, which may lead to detachment.  The flow chamber can be 
mounted on the stage of an inverted phase-contrast microscope, and by using time-lapse 
video microscopy, the dynamics of cell detachment can be examined simultaneously.  
One of the major limitations of this method is that detachment forces are usually non-
uniform along the cell surface, thus preventing analysis of these forces without making 
assumptions about the cell shape
153-154
.         
1.4.3 Electrochemical methods 
In recent years, experimental methods based on electrochemical impedance 
analysis are becoming more and more popular because of their versatility for studying 
cell-substrate interactions in real-time.  The basic principle of using this technique was 
first introduced by Giaever and Keese in 1984 and has been continuously optimized ever 
since
155
.  This technique was named electric cell-substrate impedance sensing (ECIS)
155
.  
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The basic principle behind this method involves two gold electrodes, one small working 
electrode and a relatively larger counter electrode, and the electric circuit, which is 
completed by the cell culture medium on top of the cell layer.  This technique is based on 
measuring changes in the electrochemical impedance of the gold film electrodes at 
different frequencies (alternating current).  Since the cells behave as insulating particles, 
whether the current flows through the cells or around the cell bodies, an increase in 
impedance occurs due to the presence of cell bodies on the electrode surface compared to 
a cell-free electrode
156
.  
 This technique makes it possible to study cell attachment and spreading when the 
cells are seeded on an ECIS electrode surface.  The ECIS measurements allow examining 
the kinetics of cell spreading
156
.  Once the cells form a confluent monolayer the 
impedance becomes stationary as long as the cells do not change their shape.  When this 
happens, ECIS can be used to study changes in cell shape.  ECIS can be applicable in 
many research areas to study cell morphology
155, 157
, cytotoxicity screening
158-159
 , and 
GPCR-mediated signal transduction
160
 among others
158, 161-162
.  The measurements 
acquired with this technique rely mostly on small amplitude currents and voltages such 
that the cells are not damaged in any way by the electric field used.  This technique is 
considered to be non-invasive, thus making it a well suited method to study cell-surface 
interactions
163-164
.    
1.4.4 Acoustic techniques 
There are several acoustic methods that have been developed over the past years 
that are able to provide valuable information about cell-surface interactions.  One of the 
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most widely used devices is the quartz crystal microbalance (QCM).  This instrument has 
a long record as a mass-sensitive tool to study adsorption at the solid-liquid interface.  It 
is non-invasive and it has a time-resolution that is much better than what is usually 
needed for most cell-related studies.  For many years the QCM technique has been used 
as a well-established and accepted tool for studying deposition processes of thin material 
films in the gas phase or in vacuum.  Recent progress in developing better oscillator 
circuits to monitor adsorption processes in aqueous environments has paved the way to 
study the detection of protein adsorption or cell adhesion processes under physiological 
conditions
165-167
.  The QCM has shown versatility
168-170
 in chemical
171
, physical
172
, 
biological
172-173
 and biomedical research
174
, thus making it an ideal candidate to study 
biological processes, such as cell adhesion.    The QCM technique will be explained in 
great detail in chapter 2.   
This thesis work will address monitoring the process of cell adhesion, as well as 
the signaling pathways, that mediate cell adhesion, focusing mostly on the EGFR 
downstream signaling pathways with QCM-D.   First, the acoustic instrument used to 
detect cellular responses will be described (chapter 2).  Second, the effects of the 
overexpression of EGFR on the ligand-induced restructuring of focal adhesions using two 
different cell lines (MCF-10A and MCF-10A-EGFR) will be described (chapter 5).  
Third, the inhibition of the EGF-induced response in MCF-10A-EGFR cells using 
various inhibitors will be examined (chapter 6).  Finally, EGCG-induced ROS formation 
on A431 cells will be described (chapter 7).  Chapters 3 and 4 describe the methods and 
materials used in this work.    
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Chapter 2:  Introduction  
 Although, traditional molecular assays can only measure molecules one at a time, 
they have made it possible to study various enzymes and substrates that are important for 
several cellular processes, including cell signaling.  Due to the advancement in molecular 
biology in recent years, analytical techniques have advanced to meet the increasing 
demands for the characterization of molecules in living cells using high temporal and 
spatial resolutions as well as high throughput
175-182
.    Since most signaling proteins work 
in a large and complex network to conduct the propagation of signals within a cell to 
understand how the cell responds to environmental cues, there is an increasing demand 
for assays that can allow the investigator to study cellular responses at the whole cell 
level.   Label-free sensors satisfy this need by measuring cellular responses with high 
temporal resolution.  These types of biosensors have the ability to analyze specific 
molecular interactions, such as cell adhesion, signaling, migration, proliferation and 
differentiation, without the use of chemical labels because they are non-invasive.   
Label-free biosensors work with the use of a transducer to convert a stimulus-
induced cellular response into an electric signal
183-184
.  A biosensor can be described as a 
combination of a receptor for  molecular recognition and a transducer transmitting the 
interaction information via an electrical signal
183
.  This thesis work introduces the use of 
a resonator based mass sensor known as the quartz crystal microbalance with dissipation 
monitoring (QCM-D).  The QCM-D is a powerful bioanalytical tool that is able of 
assessing the properties of cells.  This chapter describes the QCM technique and 
compares it with other techniques. It begins with a discussion of the fundamental 
concepts underlying the function of resonance and resonators (section 2.1).  This is then 
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followed by a description of piezoelectric quartz as resonators, with an emphasis on AT-
cut quartz crystals.  Section 2.2 discusses the operation of QCM; Section 2.3 describes 
other mass sensing techniques based on resonators other than quartz crystals; in section 
2.4, the versatility of QCM and its various applications are outlined and section 2.5 
compares QCM with optical techniques for detection.   
2.1 Resonators and Resonance 
Objects such as quartz crystals that experience resonance due to oscillations inside 
them are called resonators. The vibrations inside them travel as waves, at an 
approximately constant velocity, bouncing back and forth between the sides of the 
resonators.  The resonant frequencies of resonators are usually spaced equally in 
multiples of the lowest frequency, which is the fundamental frequency.  These multiples 
are referred to as overtones
185-186
.         
Resonance occurs when an oscillating system is driven at a frequency that is close 
or identical to one of its natural frequencies.  At these frequencies the system stores 
vibrational energy.  The storage and transfer of this vibrational energy between different 
mode shapes is what allows resonance to occur.  Every time the transfer of this 
vibrational energy occurs, there are some small losses from cycle to cycle, called 
damping.  Damping forces, such as friction and viscous drag can cause loss of energy 
from the system into the environment, the loss in energy occurs in the form of heat
186
.  
Therefore, the lost energy is not restored to the system, and the oscillations will decay 
exponentially.  This is known as “damped resonance,” and although the amplitude of 
oscillations will die down with the loss of energy over time, the frequency of the 
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oscillations will remain the same.  If the amount of external energy supplied to the system 
is equal to the energy loss, then the oscillations will continue indefinitely, thus causing 
the system to oscillate with the same frequency as that of the external force.        
2.1.1 Quartz Oscillators and Piezoelectricity 
When an alternating current is applied to a quartz crystal, it resonates at the 
frequency of the applied current due to the converse piezoelectric effect.  The direct 
piezoelectricity can be defined as the internal generation of electrical charge separation 
due to the applied mechanical force
187
.  The converse piezoelectric effect, as seen in 
quartz oscillators is when the alternating electric current applied to the crystal results in 
the generation of mechanical vibrations in the crystal
188
.      
2.1.2 Quartz Crystal 
Quartz is the second most abundant mineral on earth, it is made out of silicon and 
oxygen atoms (chemical formula: SiO2).  It consists of a framework of silicon-oxygen 
tetrahedra, SiO4, where each oxygen atom is shared between two tetrahedral silicon 
atoms, thus giving the overall formula SiO2
189
.  Crystalline quartz occurs naturally in 
nature, but it is very expensive and difficult to find.  Many quartz crystals are grown 
commercially in the laboratory and subjected to various processes to increase their 
purity
190
.  Quartz is the stable form of SiO2 at atmospheric temperature and pressure.  It is 
denser than tridymite and cristobalite
190
.  The quartz that is needed for resonator work is 
α-quartz, which is the more thermodynamically stable form of quartz at higher 
temperatures (up to 557 
o
C)
191
.  At temperatures close to the melting point of quartz 
(1723 
o
C), other forms of quartz exist, but they are not piezoelectric
192
.  There are two 
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naturally occurring forms of α-quartz, which are right and left handed (Figure 2.1).  
These two forms are both present in nature, but the commercially-made quartz is right-
handed and it is the only form considered in this thesis work.  Unless otherwise stated, 
the term quartz will refer to the single α-quartz193.   
The piezoelectric effect only occurs in crystalline materials that are members of 
the noncentrosymmetric space group, called acentric materials
187-188
.  Quartz has a single 
axis of threefold symmetry (trigonal axis) and three axes of twofold symmetry (diagonal 
axis) that are perpendicular to the trigonal axis.  The coordinate system used to describe 
the physical properties of quartz is rectangular coordinates OXYZ in which the Z-axis is 
parallel to the trigonal axis and the X-axis is parallel with the diagonal axis.  The Y-axis is 
chosen to form a right-handed coordinate system
194
.   
Quartz crystals are found in two main types of cuts, X-cut and AT-cut crystals
195
.  
The X-cut crystal is cut normal to the x-axis and this is where its name comes from.  
When provided with electrodes on its major faces, a voltage applied to the electrodes will 
produce a strain along the thickness of the plate, e.g., parallel to the x-axis.  In fact, the 
first quartz crystal controlled oscillators were based on X-cut crystals.  The main problem 
with this type of crystal is the large frequency drifts with temperature; this created a need 
for other cuts that were less temperature-sensitive
196
.        
In 1934 the first AT-cut crystal was introduced by Lack et al.  The “T” means that 
the quartz is a temperature-compensated cut; and the “A” stands for the first of such cuts 
to be discovered
196
.  The AT-cut crystal, which is the one used in this thesis work, must 
be cut to a specific orientation with respect to the crystal axis.  AT-cut crystals are 
obtained by shearing the quartz crystal at an angle of 35
o
 from the z-axis, and it is one of 
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the most widely used cuts for applications in which the resonating crystal acts as a 
reference frequency source
196
.  The z-axis in the quartz crystal is the axis of the three-fold 
symmetry in the quartz.  This indicates that all the physical properties repeat each 120
o
 as 
the crystal rotates around the z-axis.    This is the main reason why the AT-cut crystal has 
become very popular in frequency control applications.  Unlike the X-cut crystal, 
applying an electrical field across the AT-cut crystal does not generate a strain in the 
thickness direction but instead it generates a shear strain (Figure 2.2).  This is due to the 
electrical field not being parallel to the diagonal axis in an AT-cut crystal as it is in an X-
cut crystal.  As a result, an alternating electric field induces shear waves and, similarly to 
the X-cut crystals, resonance occurs when the thickness of the plate is an odd integer of 
half wavelengths of the induced wave
197-199
.  Figure 2.1 depicts various quartz crystal 
cuts with respect to the crystal orientation.  Also depicted is the AT-cut
200
.         
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Figure 2.1:  Schematic representation of a quartz crystal.  The image also shows the crystallographic orientation for the 
AT-cut of quartz crystal along with other cuts.  AT-cut is the most popular cut of quartz crystal in use196.  
 
  
 
Figure 2.2:  Schematic illustration of the shear strain induced in an AT-cut crystal.  The panel on the right shows a 
crystal at resonance197.    
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There are different modes of oscillations of the quartz resonators that can be 
induced, which are shown in Figure 2.3.     The type of deformation occurring in the 
crystal when an electric field is applied over the electrode depends mainly on the cut of 
the crystal used, e.g., AT-cut crystal, which can be used for different applications.   
 
Figure 2.3:  Different mode shapes of vibration of the quartz crystal196. 
 
2.1.3 Quality (Q) factor  
AT-cut quartz crystals have very stable frequency and high quality (Q-) factor.  
The high Q factor is defined as a dimensionless parameter that describes how 
underdamped a resonator or oscillator is with respect to its center frequency
201
.  The 
material properties of a single AT-cut quartz crystal are very stable over time, 
temperature, and other environmental changes.  The acoustic loss of quartz is very low, 
which shows one of the main properties of a quartz resonator, its extremely high Q 
factor
201
.  A second important property of the AT-cut quartz is its stability with respect to 
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temperature variation.  The third important characteristic of the quartz crystal is related to 
the stability of its mechanical properties.   
As the resonance frequency of a QCM increases, so does the change in frequency 
per unit mass deposited on its electrodes.  This is why it is important to have a quartz 
crystal that can operate at higher resonant frequencies in order to attain better mass 
sensitivity.  Frequency stability of the resonator can be determined by a dimensionless 
quantity known as the Quality Factor (Q-factor) of the resonator.  The Q-factor of a 
resonator is the ratio between the energy input into the resonator, divided by the energy 
lost in the resonator per oscillation cycle
202
.   
A higher Q factor is usually an indication of a lower rate of energy loss relative to 
the stored energy of the resonator, thus causing the resonator to die down more slowly.  
This type of resonator will usually resonate with greater amplitudes, but will have a 
smaller range of frequencies around the particular frequency at which they resonate.  
These ranges of frequencies are usually referred to as the bandwidth.  As a result, 
resonators that have high Q-factors oscillate with a smaller range of frequencies, they are 
a lot more stable and they have low damping
203
. 
The Q factor is described by the following equation, 
ycleipatedpercEnergyDiss
edEnergyStor
Q  2                          (2.1) 
In this expression, Q defines the ratio between energy stored to the energy dissipated per 
radian or per cycle (2π radians).            
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2.2 Resonators and mass sensors  
As mentioned in previous sections, the quartz crystal operates in thickness shear 
mode, with resonance frequency of the crystal changing with the deposition of mass on 
the electrodes.  Since QCM is not the only mass sensing resonator, this section will 
briefly describe some of the other resonators used for mass sensing such as cantilevers, 
carbon nanotubes, surface acoustic waves (SAW), and film bulk acoustic resonator 
(FBAR). 
2.2.1 Cantilevers as mass sensors 
Micro-cantilevers are devices that can act as physical, chemical or biological 
sensors by detecting changes in cantilever bending or of the vibrational frequency
204-206
.  
The natural resonance of the cantilever tends to change when the mass on them changes.  
Micro-cantilevers are very sensitive as mass detection sensors, usually in the femtogram 
range (Figure 2.4) 
205
.  They can be excited into resonance by a number of ways, such as 
piezo-resistive deflection detection
207
, optical reflection
208
, capacitive deflection 
detection
209
, interferometry deflection detection
210
, optical diffraction grating deflection 
detection
211
 and charge coupled device detection methods
212
.     
The bending and resonance frequency shifts of a cantilever can be measured with 
the atomic force microscopic (AFM) technique
207
.  The main advantages of cantilevers 
are their sensitivity based on the ability to detect cantilever deflection, their ability to be 
fabricated into a multi-elements sensor array, and their ability to work in air, vacuum or 
liquid
207
.   
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Figure 2.4:  Schematic of optical readout technique commonly used in cantilevers. 
 
2.2.2 Surface acoustic wave sensors  
Surface acoustic wave sensors (SAW) are made of a thick plate of piezoelectric 
material, usually ST-cut quartz, lithium niobate or lithium tantalate, where Rayleigh 
waves propagate along the upper surface
213
.  Unlike bulk wave resonators, the resonance 
frequency of the SAW devices is determined by the spacing of the interdigitated 
electrodes, which is an inter-digital transducer (IDT) that is created by two identical 
comb-like structures arranged in an alternating pattern.  SAW resonators can be used as 
high-frequency reference elements in filters and oscillators, but they can be designed to 
be responsive to a variety of quantities to have them work as sensors
214
.  SAW resonators 
have a high Q factor that allows for high frequency stability at relative high frequencies 
thus allowing lower mass resolution and hence detection limits.   
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2.2.3 Film bulk acoustic resonator  
Film bulk acoustic resonator (FBAR) works in a similar manner as a QCM.  Their 
resonance frequency changes when a mass is deposited on the surface of the resonator. 
They are also much smaller in size and they operate at a much higher resonant frequency.  
The main different between FBAR and QCM is that FBAR uses a longitudinal acoustic 
wave, while QCM uses a shear wave.   The FBAR sensors are made of a thin 
piezoelectric layer, which is sandwiched between two electrodes, just like in a QCM 
215-
216
.  Bulk longitudinal waves are generated in the piezoelectric layer when an AC field is 
applied
216
.  Since there are not that many reports in the literature using FBAR in liquid 
environments for biochemical applications, the effects of liquid properties on the FBAR 
resonant frequency are not yet known, Zhang et al. reported a systematic study of an 
FBAR operating in liquid to evaluate its potential for biochemical sensing
217
.  In this 
particular study, they developed a TiO2-coated FBAR for sensitive mass sensing of K
+
 
ions in a liquid environment.        
Comparing all of the aforementioned mass sensors, the QCM sensor displays most 
of their characteristics, including frequency stability, insensitivity to temperature, high 
reliability, and the ability to work in highly viscous environments. 
2.3 Quartz Crystal Microbalance 
The main component of a quartz crystal microbalance (QCM) is a thin AT-cut quartz 
wafer sandwiched between two metal electrodes (Figure 2.5).  Due to the piezoelectric 
nature of the quartz crystal, an oscillating current applied by the electrodes results in 
oscillating in-plane shear of the quartz crystal
218
.  Resonance is excited when an AC 
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voltage is applied with a frequency close to the resonant frequency (f0) of the particular 
crystal.  The resonant frequency of a QCM changes when the mass on one of its 
electrodes changes.  In 1959, Sauerbrey provided a description and experimental proof of 
the mass-frequency relationship
219
.  Sauerbrey demonstrated that by adding mass to the 
surface of the quartz crystal there is a frequency decrease, which is proportional to the 
added mass, given that the mass is small compared to the weight of the crystal, rigidly 
absorbed and evenly distributed over the crystal surface.  The linear relationship between 
the changes in frequency, ∆f, and adsorbed mass, ∆m, are referred to as the Sauerbrey 
relationship
219
, 
nf
n
C
m                                                         (2.2) 
Where ∆fn is the change in resonant frequency at the vibrational mode number n, ∆m 
is the mass deposited per unit area of crystal surface, and C is the mass sensitivity 
constant of the instrument.  For a 5 MHz quartz crystal, C is 17.7 ng/Hz cm
2
.  The 
sensing principle is schematically summarized in Figure. 2.5. 
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Figure 2.5:  (a) Schematic diagram of a quartz crystal sensor, (b) cross sectional view of the sensor.  Image adapted 
from QSense (http://www.biolinscientific.com/q-sense/). 
 
The sensitivity of the sensor crystal to coupled mass is not uniform.  It follows a 
Gaussian distribution, showing a maximum at the center of the disk and reducing towards 
the edges of the sensor
218, 220
.  Separately, the amplitude of the evanescent field generated 
by the vibrational shear wave of the QCM diminishes exponentially as the distance from 
the surface of the sensor crystal increases.  The penetration depth (δ) of the shear wave 
into a liquid coupled to the sensor crystal is described by: 
nf

                                                       (2.3) 
Where η is the viscosity of the liquid, ρ is the density of the liquid, and fn is the frequency 
at the n
th
 vibrational mode
218
.     
The early applications of the QCM were mostly for gas-phase and vacuum 
monitoring of metal plating in vacuum deposition systems
221
.  Later other applications, 
such as measuring dry etch rates, oxidation rates on metal surface, and various gas 
adsorption and desorption processes, were utilized
222
.  All of these applications took 
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advantage of the high sensitivity of the instrument.  In 1980, the Nomura group 
demonstrated that the QCM could also be used for liquid phase applications
223
, thus 
establishing a new set of applications in bioscience and biotechnology
31, 173, 224
, in 
particular biosensor applications.  The main problem of applying QCM to many liquid 
applications was that the liquid phase incorporated viscous and elastic contributions to 
the frequency change, thus violating the Sauerbrey relationship, which assumed that the 
mass adsorbed must be rigidly adsorbed
225
.  In order to keep the QCM technique as a 
useful sensor technology, two new requirements are needed, which would have to include 
a technical solution that could potentially provide information about the changes in 
energy dissipation, D, of the oscillating system and it would also have to provide a 
suitable theory for interpreting these data.     
2.3.1 Quartz Crystal Microbalance with Dissipation Monitoring 
Since the dissipation factor, D, provides valuable information, a new way to 
measure both dissipation and frequency simultaneously was developed
201
.  Dissipation is 
a parameter that allows quantifying the damping in the system, and it is usually related to 
the sample’s viscoelastic properties.  There are two ways to obtain information about 
changes in D, one is via impedance analysis
226
 and the second one is by monitoring the 
decay of the crystal’s oscillation after rapid excitation close to the resonant frequency201, 
218
.  The latter technique will be addressed in more detailed in this work. 
The principle of measuring changes in frequency (f) and energy dissipation (D) 
simultaneously is to periodically switch on and off the driving power of the sensor and 
record the output voltage from the freely decaying oscillator.  The amplitude of 
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oscillation decays over time while the driver circuit is disconnected
197, 227
.  The decaying 
voltage output with a frequency given by the resonant frequency of the quartz crystal (f0), 
is mixed with a reference frequency (fR) and filtered with a low-pass band filter.  This 
gives an output frequency (f) that is the difference between fR and f0.  The dissipation 
parameter is described by, 
 n
n
f
D
1
        (2.4) 
where τ is the decay time constant.  The energy dissipation is dimensionless and it is 
defined as, 
             
stored
Dissipated
E
E
Q
D
2
1
                (2.5) 
Where Q is the quality factor, Estored is the energy stored in the oscillating system and 
EDissipated is the energy dissipated during one oscillatory cycle
197
.   This technology was 
commercialized by Q-Sense in 1996 (Q-Sense Gothenburg, Sweden), and it became 
known as quartz crystal microbalance with dissipation monitoring (QCM-D), which 
allowed the simultaneous measurement of changes in both frequency (∆f) and dissipation 
(∆D) at various vibrational modes (n = 3, 5…).   
The resolution of frequency and dissipation in liquids is on the order of ± 0.1 Hz 
and < 1 x 10
-7
, respectively, while in vacuum or air it is at least a factor of ~10 better.  As 
a comparison, the ∆f and ∆D responses for protein, vesicle, or cell adsorption are usually 
around 10 – 100 Hz and 0.5 – 10 x 10-6, respectively, while for viscoelastic films (>100 
nm) they are usually one order of magnitude larger.  The QCM-D allows for probing f and 
D values at odd harmonics (n = 3, 5…), when a mass layer is deposited on the crystal 
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surface, the additional mass film increases the resonator’s thickness and the resonant 
frequencies of the crystal are diminished.  The QCM can only resonate at half 
wavelengths, meaning that the fundamental frequency has a wavelength twice that of the 
thickness of the crystal.  As a consequence, the QCM cannot resonate at even harmonics 
(n = 2, 4, 6...) because there is no real charge separation associated with a symmetric 
wave.  Although, the QCM-D can measure ∆f and ∆D simultaneously, in our studies on 
cells, there was no apparent connection between the features of the ∆D- and ∆f-responses.  
While the ∆D curves respond to dosage with a ligand or drug, the Δf-curves showed no 
measurable response and no sensitivity to dose.  In fact, all of the Δf-curves were the 
same no matter what the ligand or drug or dosage of either.  
In theory, there are resonances at even-numbered harmonics of the fundamental 
frequency (n = 1), but they can only be excited mechanically, and they would only have 
an amplitude inside of the quartz crystal, thus making the readings meaningless because 
what we want to study is the interaction between the adsorbed material on the crystal 
surface
228
.     
2.4 QCM Technique for bioanalytical applications 
In bioanalytical applications the D factor and the extracted viscoelastic parameters 
are critical for many applications.  For example, in cellular adsorption applications, the 
QCM frequency and Sauerbrey relationship will underestimate the interaction between 
the adsorbed mass of cells and the crystal surface, since the shear wave of the oscillating 
quartz crystal is attenuated out before reaching the center of the cell.  The penetration 
depth depends on the material being used and it is usually on the order of 250 nm.  
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Viscous materials, such as adhered cells, do not follow the sensor oscillation perfectly; 
this leads to internal friction (due to deformation) in the adlayer, thus creating dissipation.  
In order to fully characterize the adsorption of the viscoelastic material, such as cells, it is 
important to monitor the dissipation parameter. 
As previously mentioned, one of the main advantages of the QCM-D is to measure 
∆f and ∆D simultaneously; another major advantage of this technique is the flexibility in 
the choice of substrate.  In theory, any material can be evaporated or deposited to a 
thickness in the ~nm - µm range on the surface of the crystal of the QCM-D.  This 
indicates that a surface can be designed and monitored during the preparation process and 
this same surface can be used as a platform for studying other biomolecular interactions.  
This allows for the development of biosensors that can eventually be used for biological 
applications of the QCM-D (Figure 2.6).  There are such a large number of bio-analytical 
applications for the QCM, but a comprehensive review of these is beyond the scope of 
this thesis.  In the following sections an attempt has been made to cover some of these 
applications to illustrate the versatility of the sensor. 
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Figure 2.6:  The QCM can be used for several applications, a few of which are depicted in this figure.   
 
2.4.1 DNA Biosensors 
DNA studies using the QCM-D technology have featured a wide variety of 
applications.  This includes investigating the effects of ligands on estrogen transcription 
factors
229
.  Nguyen et al. have used QCM-D to study the adsorption of linear and 
supercoiled plasmid DNA onto a “natural organic matter” under various salt conditions to 
get a better understanding of DNA adsorption onto a variety of solid surfaces
230-232
.  In 
another study done by Rawel et al., the QCM-D technique was used to develop surface 
scaffolds using single- and double-stranded DNA surfaces
233
.  DNA itself has also been 
used as a tool by Wikstrom et al.,
234
 and Graneli et al.
235
 to investigate phospholipid 
vesicles to determine binding dynamics in coagulation studies and also to use its 
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complementary strands to build up 3-D networks of proteoliposomes to membrane 
proteins.  In all of the studies described in this section, the results obtained were based on 
the ∆f and ∆D.    
2.4.2 Proteins  
Around the same time that the QCM-D technique was used for DNA studies, 
results from investigations into antibody-antigen interaction were also published
236
.  One 
of the major applications of the QCM-D technique is to measure the amount of protein 
adsorbed onto the surface, in order to determine whether or not the surface material used 
resists or promotes protein adsorption.    A few examples of protein adsorption include a 
study done by Wittmer et al. showing the formation and cell attachment properties of a 
fibronectin terminated multilayer film composed of linear polyelectrolytes poly(L-lysine) 
(PLL) and dextran sulfate (DS)
237
.  In this study they found that fibronectin adsorbs better 
to  a polycation-terminated film, and cells generally spread to a greater extent on films 
that are coated with a layer of fibronectin
237
.  They measured the ∆f as well as ∆D to 
determine mass changes and viscoelastic properties of fibronectin to characterize the 
adsorption process.  The measured parameters in this study, correspond to adsorbed mass 
and to the mechanical properties of the adsorbed layer as it formed
238
.  Another 
interesting application involving proteins deals with measuring the hydration-dehydration 
process of an adsorbed human serum albumin film.  The QCM-D technique has also been 
used by various groups to measure small molecule-protein interactions
239-240
.    
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2.4.3 Lipids 
   Most of the QCM applications relating to phospholipids describe the formation 
of supported lipid bilayers (SLBs).  The use of QCM-D allows for the detection of SLBs 
by sensing trapped water inside the intact lipid vesicle when they adsorb on the surface; 
when they break off to form bilayers, the dissipation decreases, which is usually an 
indication of loss of water and the formation of a more rigid structure
238
.  In this 
particular study, it was shown that lipid vesicles, when exposed to a surface, can form 
different structures, such as monolayer, bilayer or intact vesicle.  The different structure 
formed depends on the properties of the surface used.  For example, when a SiO2 surface 
was used a layer of intact vesicles precedes the formation of the bilayer 
238, 241-242
.  QCM-
D has also been used to study the interaction between lipid molecules and enzymes, such 
as lipase because this type of substrate-enzyme interaction is central to a wide range of 
biomedical systems
243
.            
2.4.4 Drug analysis  
Due to high sensitivity of the QCM-D technique, it is also used to detect drug 
components present in very small quantities of the sample, the QCM-D technique can 
sense conformational and structural changes in molecular layers or whole cells on the 
sensor surface.  All of these characteristics have great potential within the drug discovery 
field, enabling both the detection of potential new drugs in drug target screening and also 
to improve the understanding of target interaction mechanisms.  There have been studies 
done in which the protein conformational changes caused by small compounds are 
investigated with the QCM-D technique.  In one study, the unfolding of the protein 
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plasminogen was characterized after the addition of lysine analogs 
244
.  Similarly, the 
conformational re-arrangement of the HIV-1 envelope protein has been assessed.  In this 
particular study the protein was immobilized on the QCM-D sensors and its interactions 
with various compounds were followed in real time
245
.  Likewise, proteins involved in 
human protein misfolding diseases, such as Alzheimer’s disease, can be studied using 
QCM-D
246
.  Protein drug aggregation is an important factor in drug development and 
manufacturing.  It is important to understand proteins’ aggregation propensity and the 
QCM-D technique has been used to monitor the adsorption and aggregation of 
therapeutic monoclonal antibodies and proteins
247-248
.  In all the aforementioned studies, 
changes in the energy dissipation proved crucial for having a better understanding of 
conformational events.      
2.4.5 QCM as immunosensor 
Immunological biosensor antibodies have been used to coat the surface of the 
QCM-D to make it work as an immunosensor.  These antibody coatings enable the QCM-
D surface to be more bioselective 
249-251
.  QCM-D as an immunosensor has been used to 
detect bovine serum albumin (BSA) antibodies by coating the resonator with nyebar C 
and BSA
252
.  The adsorption of antibodies is a method that is commonly used for the 
detection of several analytes, including HIV antibodies
253-254
.  In order to immobilize 
antibodies onto a quartz crystal surface, Protein A and G can be used for this task.  They 
both used the ∆D to detect viruses and other analytes 255-257.   
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2.4.6 Cell adhesion and cell function   
The application of QCM to study whole cells has started to attract more attention.  
The QCM has been shown to be able to monitor the attachment and spreading of cells on 
the surface of the quartz crystal 
26, 258-262
, and it has also provided the assessment of the 
kinetics of these processes
27, 263-264
.  Work done by Heitmann et al. suggests that the 
QCM technique can be considered non-invasive to mammalian cells because the lateral 
displacement of the surface sensor crystal during oscillation rarely exceeds 1 nm 
265
.  The 
non-invasive character of this technique has allowed for the emergence of additional 
applications, such as the study of cellular responses to external chemical and biochemical 
stimulation
266-270
.  This section will be explained in more detail in the following chapters.         
2.5 Current techniques based on optical transducers 
There are various optical detection methods that can also be used for bioanalytical 
purposes, some of which include surface plasmon resonance (SPR) 
271-272
, ellipsometry 
272-273
, resonance mirror technique (RM) 
274
, and reflectometric interference spectroscopy 
275
.  All of these techniques detect the refractive index n and the film thickness d or the 
effective optical thickness (nd) (Figure 2.7).  
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Figure 2.7:  Schematic representation of the different optical label free techniques:  (a) Surface Plasmon Resonance 
Spectroscopy (SPR), (b) resonant mirror (RM), (c) spectral ellipsometry, (d) reflectometric interferometric 
spectroscopy (RIFs). 
 
SPR is the most well-known optical sensing technique, (Figure 2.7a).  Surface 
plasmons are surface electromagnetic waves that propagate in a direction that is parallel 
to the metal/dielectric interface.  Surface plasmon resonance occurs by optical excitation 
only if the wave of the incoming light is able to interact with the free electrons of the 
metal and if the energy and momentum of the incident light beam correspond to those of 
the surface plasmon
276
.  In this technique, the compound being studied is immobilized on 
a glass prism covered with a thin evaporated metal film
277
.  Plasmons are excited by the 
evanescent wave thar induces oscillation of free electrons in the metal.  Once excited, 
these plasmons can generate another electromagnetic field, which penetrates the 
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compound being studied.  The wave numbers and surface plasmons match at a particular 
angle of incidence, which leads to the energy of the photons being transferred to 
plasmons
277
.  SPR has been previously used to investigate cell adhesion 
278
, lipid bilayer 
279
, and ligand-binding interactions 
280
.  One of the main differences between SPR and 
QCM-D is in sensitivity.  QCM-D systems are more sensitive for water-rich and extended 
layers, while SPR system works better for compact and dense layers.  QCM-D is able to 
measure thicker films, while SPR has greater limitations concerning film thickness.  The 
reason for this difference is due to the different physical principles by which the coupled 
mass is measured.  In an SPR system, the estimate data for the mass-uptake is based on 
the difference in refractive index between the adsorbed biomolecules and water displaced 
by the molecules upon adsorption.  In other words, the water associated with the coated 
film is not included in the mass determination.  In the case of the QCM-D, changes in 
frequency measure water coupled as an effective mass via direct hydration in the 
adsorbed film.  As a result, the SPR response is proportional to the coupled molar mass, 
while the QCM-D can sense the layer as a hydrogel composed of the macromolecules and 
coupled water.  Additionally, SPR measures only one parameter; the additional 
information found in energy dissipation data from QCM-D allows a more detailed 
interpretation
271, 281
.      
Spectral ellipsometry is a less common method to monitor biological processes, but 
it is still a useful technique because it allows the determination of thickness and refractive 
index of the adsorb layer
273, 282
.  Ellipsometry works by measuring the change of 
polarization upon reflection and compares it to a model.  The nature of the polarization 
change is based on the sample’s properties283 (Figure 2.7c).     
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The RM technique works very similar to SPR (Figure 2.7b).  It is based on a prism 
coupler; the coupling conditions for two orthogonal waves of linear polarized light are 
met at different angles of incidence.  The polarized light experiences a phase shift in the 
waveguide, and depending on this phase shift and the interaction from the adsorption 
layer on the interface, the refractive index of the analytes adsorbed on the surface can be 
found
274
.     
The reflection interference spectroscopy directly determines the effective thickness 
of the films found on the surface, thus providing data on the surface concentration of the 
analyte (Figure 2.7d).  When the film is illuminated with white light through a substance, 
it is reflected at both the interfaces of the film.  If monochromatic light is used, then one 
can observe either constructive or destructive interference, depending on the wavelength, 
and hence a periodic modulation of the reflecting light intensity results.  The film 
thickness plays an important role in the position of the minima and maxima at a particular 
refractive index and angle of incidence.  This thickness is what allows measurements of 
thickness changes of up to 1 pm resolution
275
. 
In this chapter, we have looked at various mass sensors.  Also, several applications 
of QCM in a large number of areas were described along with the versatility of the 
instrument in many biological applications.  However, in order to increase the versatility 
and applicability of the device in biological applications and to compete with other mass 
sensing techniques, it is important that the QCM-D be used as a sensor to exploit its 
unique dissipation factor to quantitatively assess kinetic aspects of cellular processes, to 
monitor structural changes in the adhered cells, and to use it as a sensing platform for 
drug screening.  Because it is noninvasive, the QCM-D technique potentially has a broad 
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range of applications in the fundamental study of cellular processes, such as cell signaling 
and trafficking and mechanotransduction, and holds promise for drug and biomarker 
screening.  This type of resonator is expected to find applications in many more areas 
than the ones presented here.   In this thesis an acoustic sensor is used as a biosensor to 
measure cell adhesion, to evaluate drug effects on cellular responses, to evaluate kinetic 
aspects of cellular processes and to serve as a sensing platform for the detection of 
reactive oxygen species (ROS).   
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Chapter 3: Materials  
3.1 Established cell lines  
Table 3.1:  Cell lines 
Cell line name Source Manufacturer 
A431 Human epidermoid carcinoma ATCC number CRL-1555 
MCF-10A Human mammary epithelial ATCC number CRL-10317 
MCF-10A-EGFR 
Human mammary epithelial 
overexpressing EGFR 
From stable transfection of 
MCF-10A, overexpressing 
wildtype EGFR
284 
 
3.2 Cell culture reagents 
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Carlsbad, CA) 
Dulbecco’s modified Eagle’s medium: nutrient mix F12 (DMEM/F12, Invitrogen, 
Carlsbad, CA) 
Fetal bovine Serum (FBS, Invitrogen, Carlsbad, CA) 
Horse Serum (Invitrogen, Carlsbad, CA) 
Penicillin/Streptomycin (Invitrogen, Carlsbad, CA) 
Trypsin-EDTA (Invitrogen, Carlsbad, CA) 
Hydrocortisone (Sigma-Aldrich, St. Louis, MO) 
Cholera toxin (Sigma-Aldrich, St. Louis, MO) 
Insulin (Sigma-Aldrich, St. Louis, MO) 
Epidermal growth factor (EGF, Prepotech, Rocky hill, NJ)  
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3.3 Buffers and Media 
The distilled water used was filtered using Direct-Q 3 UV system (EMD Millipore, 
Billerica, MA).  1x phosphate saline buffer (20X PBS, Teknova, Hollister, CA) was 
prepared with distilled water and autoclaved at 121 
o
C and 2 x 10
5
  Pa for 20 min.  20 
mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, Invitrogen, Carlsbad, 
CA)  was prepared with Hanks balanced salt solution (HBSS, Invitrogen, Carlsbad, CA) 
with Ca
++
/Mg
++
 (1 x).  For fixation of cells, 1X PHEM buffer was prepared with 60 mM 
piperazine-N,N’-bis(2-ethanesulfonic acid) (PIPES, VWR, Radnor, PA) 25 mM HEPES, 
10mM ethylene glycol tetraacetic acid (EGTA, Calbiochem, Darmstadt, Germany) 2 mM 
magnesium chloride (MgCl2,VWR, Radnor , PA) at a pH of 6.9.  Cell lysis buffer was 
prepared using 10 mm Tris-HCl pH 7.4, 10mm Ethylenediaminetetraacetic acid (EDTA, 
Lonza, Basel, Switzerland) and 0.5 % sodium dodecyl sulfate (SDS, VWR, Radnor, PA).              
DMEM growth medium consists of 10 % FBS and 100 IU/mL penicillin, and 100 
µg/mL streptomycin.  DMEM/F12 growth medium contains 5 % horse serum, 20 ng/mL 
EGF, 0.5 µg/mL hydrocortisone, 50 ng/mL cholera toxin, 10 µg/mL insulin, 100 IU/mL 
penicillin, and 100 µg/mL streptomycin. 
DMEM and DMEM/F12 serum free growth media were prepared with 100 IU/mL 
penicillin, and 100 µg/mL streptomycin.  
3.4 Cell staining solutions 
3 % paraformaldehyde solution (PFA, Electron microscopy sciences, Hatfield, PA) 
was prepared with 1X PHEM buffer, 16 % PFA and 0.1 % Triton X100 (Amresco, Solon, 
OH), 0.25 % ammonium chloride (Amresco, Solon, OH) was dissolved in 1 X PBS 
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buffer and 2 % bovine serum albumin (BSA, ThermoFisher Scientific, Waltham, MA) 
was dissolved in 1 X PBS and 0.1 % Triton X100.    
3.5 Antibodies 
 
Table 3.2:  Antibodies 
Antibody Source Concentration Manufacturer 
Monoclonal mouse 
anti-vinculin  
Mouse 1:500 Invitrogen (Carlsbad, 
CA) 
Alexafluor 546  Goat 1:200 Invitrogen (Carlsbad, 
CA) 
 
3.6 Inhibitors 
 
Table 3.3:  Inhibitors 
Inhibitor Stock Concentration Manufacturer 
Cytochalasin D 10 mM Enzo Life Sciences (Farmingdale, 
NY) 
LY294002 10 mM Cayman Chemical Company (Ann 
Arbor, MI) 
L-779450 (RafKinase 
Inhibitor IV) 
72 mM Calbiochem (Darmstadt, Germany) 
PD158780 10 mM EMD Bioscience (Darmstadt, 
Germany 
U73122 1 mM Cayman Chemical Company (Ann 
Arbor, MI) 
 
3.7 Other reagents and materials 
If not shown distinctly, chemicals and reagents used in experiments were obtained 
from the following companies, BD Biosciences (San Jose, CA), Sigma-Aldrich (St. 
Louis, MO), Invitrogen (Grand Island, NY), VWR (Radnor, PA), Eppendorf (NY), 
Greiner Bio-One (Monroe, NC) and Amresco (Solon, OH).    
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Solutions of 0.5 – 2 ml in volume were prepared in micro-centrifuge tubes (VWR).  
Culture flasks, conical tubes, pipettes and 12-well plates were ordered from Greiner Bio-
One (GBO).  Micropipette tips were purchased from VWR.    
 Centrifugation took place in Eppendorf-Table centrifuge 5418 and Eppendorf 
5810R.  UV-Ozone was from Bioforce nanoscience.  
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Chapter 4: Methods 
4.1 Cell culture methods - Cultivating of mammalian cells 
Cell culture work with A431, MCF-10A cells and MCF-10A-EGFR cells was 
performed under sterile conditions at the tissue culture hood (Biogard hood, The Baker 
Company).  For microscopic analysis, American optical microstar microscope was used.  
A431 cells were cultivated in DMEM medium containing 10 % FBS, 100 IU/mL 
penicillin, and 100 µg/mL streptomycin.  Cells were cultivated in T75 Corning culture 
flasks and maintained under a humidified atmosphere at 37 
o
C and 5 % CO2.  Change of 
the medium and passaging of the cells took place three times a week.  The cells were 
harvested at 95 % confluency, rinsed twice with 1 X PBS, and then treated with 0.25 % 
trypsin-EGTA at 37 
o
C for 10 min; they were then centrifuged (4 min, 1200 rpm) and 
split in ratio 1:3 – 1:8 in a fresh culture medium.  The cell medium containing 0.25 % 
trypsin-EGTA was removed and the cells were resuspended in growth medium for 
plating on sensors and/or cover slips.   MCF-10A and MCF-10A-EGFR cells were 
cultured in DMEM/F12 medium containing 5 % horse serum, 10 ng/mL EGF, 0.5 µg/mL 
hydrocortisone, 5 0ng/mL cholera toxin, 10 µg/mL insulin, 100 IU/mL penicillin, and 
100 µg/mL streptomycin, under the same conditions as A431 cells.   
4.2 QCM-D measurements      
A quartz crystal microbalance with dissipation monitoring (QCM-D E4, Q-Sense) 
was used to record changes in energy dissipation factor (∆D) and the resonant frequency 
(∆fn/n) as a function of time at the odd overtones (n = 3, 5, 7).  The QCM-D sensor 
crystals were AT-cut quartz crystal in the form of 14mm-discs with a top surface-coating 
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of a 50-mm thick film of deposited gold (QSX 301) and amorphous silicon dioxide (QSX 
303).  The crystal sensors were prepared as follows:  the QCM-D sensor was first washed 
with distilled water and ethanol, then they were dried under flowing nitrogen gas, and 
finally they were exposed to UV-ozone (Bioforce Nanoscience) for 20 min.  The sensors 
were then stored in the tissue cultured hood under UV-light for an additional 30 min.  
The sensors were then placed in a 12-well tissue culture plate along with the cells that 
had been harvested from the T75 culture flask; they were seeded on the top surface of the 
four gold sensors.  The 12-well tissue culture plate was then placed in a humidified 
atmosphere at 37 
o
C and 5 % CO2 to allow the cells to reattach and grow.   
When the cells had reached 95 % confluency, they were starved in serum free 
medium for 18 h.  Each sensor crystal with a cell layer was rinsed with assay buffer to 
remove the serum free medium, and they were then mounted in an open module (Q-
Sense) and incubated in 400 µL of the assay buffer (20 mM HEPES in HBSS buffer, pH 
7.2) at 37 
o
C.  Once stable baselines were established for all four sensors, the cells were 
then incubated in 400 µL of the inhibitor solution at 37 oC for 40 min.  Then the inhibitor 
was replaced with the same volume of the ligand in the assay buffer containing the same 
concentration of the inhibitor and the cells were incubated for 3 h.  When there was no 
pretreatment with the inhibitor, the cells were treated with the ligand for 3 h after the 
baselines were stable.  Frequency (Δf) and dissipation factor (ΔD) were monitored and 
recorded simultaneously at 37 
o
C, using the odd overtones, n = 3, 5,7,… for however 
long the experiment took place.  All QMC-D data presented in this work are for the 
overtone, n = 3.  The penetration depth of the acoustic shear wave of the QCM-D decays 
exponentially into the liquid as explained in equation 2.3 (pg. 36)
218
.  At this overtone (n 
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= 3), the acoustic shear wave has a penetration depth of approximately 100 to 150 nm 
from the surface of the 5-MHz quartz crystal sensor
285
.  This depth is coincident with the 
height of the basal region of the cell layer and therefore is sufficient for indicating 
changes therein.  Although overtones n = 5 and n = 7 show the same trends in behavior as 
that of n = 3, the signal strength is smaller, as expected for higher overtones, and are 
therefore redundant.  
4.3 Fluorescence imaging  
Cells seeded on cover slips were allowed to grow in a 12-well tissue culture plate in 
a humidified atmosphere at 37 °C and 5 % CO2. Once they reached 95 % confluency, the 
attached cells were starved in serum-free medium for 18 h. On the day of the experiment, 
these cells were pre-incubated in 1 mL of the assay buffer (20 mM HEPES in HBSS 
buffer, pH 7.2) at 37 °C for 1 h. After pre-incubation, the assay buffer was removed and 
replaced with 1 mL of the inhibitor and/or ligand dissolved in assay buffer, pre-warmed 
to 37 °C. The cells were fixed/permeabilized in a solution containing 0.1 % Triton X-100 
and 3 % paraformaldehyde in PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM 
EGTA, 2 mM MgCl2 and pH 6.9) at room temperature for 20 min. The fixed cells were 
treated first with primary monoclonal mouse anti-vinculin antibody at a concentration of 
1:500 in blocking buffer (PBS with 2 % BSA) at room temperature for 120 min, then 
were treated with secondary Alexafluor 546 goat anti-mouse antibody at a concentration 
of 1:200 in staining buffer (PBS with 2 % BSA) at room temperature for 60 min. After 
each step, the cells were rinsed with blocking buffer three times. Coverslips with stained 
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cells were mounted in Vectashield medium with DAPI (Vector Laboratories, Inc., 
Burlingame, CA). 
4.4 Inverted fluorescence microscope 
After the cells were mounted in Vectashield medium with DAPI, they were imaged 
with an inverted fluorescence microscope, Zeiss Axioplan 2 (Carl Zeiss, Thornwood, 
NY) equipped with a Plan-Apo 63x/1.40 NA objective, a deep cooled CCD camera 
(ORCA-AG; Hamamatsu Photonics).  Images were taken in the TRITC channel at 50 ms 
exposures and they were processed with the use of Slidebook 5.0 software (Intelligent 
Imaging Innovations). 
4.5 Fluorescence Quantitation 
The areal densities of focal adhesions were quantified with ImageJ software 
(http://rsb.infor.nih.gov/ij/). For each image, the background intensity was first 
determined from the fluorescence of a selected empty area. Then density of focal 
adhesions of a selected cell was obtained by subtracting the background intensity from 
the total fluorescence of immunostained vinculin
286
. Ten randomly selected cells were 
analyzed for each image. The Student t-test was used for statistical analysis of the data 
set
287
. 
4.6 Fluorescence Spectroscopy 
Fluorescence measurements were carried out at room temperature, 20 
o
C, on a 
Perkin –Elmer model LS-55 fluorescence spectrometer.  The excitation wavelength was 
set to 495 nm and the emission wavelength was set to 529 nm.  Single readings were 
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acquired with a scanning speed of 200 nm/min, and an excitation and emission slit of 5.0 
nm.  A 10 mm quartz cell was used.   
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Chapter 5: Expression of epidermal growth factor receptor on the ligand-induced 
restructuring of focal adhesions 
5.1 Introduction 
In recent years the epidermal growth factor receptor (EGFR) has obtained a lot of 
attention as a possible target for cancer therapy.  In normal cells, EGFR is involved in 
processes such as cell growth, proliferation, motility and differentiation through its 
downstream signaling pathways
288-289
.  In areas like oncology, EGFR plays a central role 
since it is involved in several steps of tumor progression such as proliferation, 
angiogenesis, invasiveness, decreased apoptosis, and loss of differentiation
9, 11
.  Binding 
of the ligand to the receptor and consequent dimerization leads to stimulation of EGFR 
and activation of various downstream signaling pathways
290
.  Due to the importance of 
EGFR signaling, an aberrant EGFR activation appears to be a significant factor in 
tumorigenesis, as well as an essential player in the aggressive growth behavior of cancer 
cell
291
.  Thus, an overexpression of EGFR is found in many types of solid tumors, and 
high expression levels appear to be linked to a more aggressive cancer
8
.  As a result, the 
examining the inhibition of its cellular actions can potentially produce substantial 
therapeutic benefits.  
 The overexpression of EGFR has also been associated with enhanced cell 
motility, which is important to tumor invasion and metastasis
120, 292-293
.  Cell motility is 
required for many essential physiological processes during development, such as cell 
migration during gastrulation, axon guidance, tissue regeneration and embryological 
development
294
.  Unregulated cell migration can be the cause for progression of tumor 
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cell metastasis
295
.  Cell migration is a complex process that encompasses a set of highly 
coordinated events, that include front extension and adhesion, trans-cellular contraction 
and rear de-adhesion
40
.  Focal adhesions are the linkages to the ECM;, they also serve as 
a biochemical signaling center to concentrate and direct various signaling proteins at sites 
of integrin binding and clustering
42, 296
.   
 The dynamic assembly and disassembly of focal adhesions is an important factor 
in cell migration
296
.  Two events take place, the composition and the morphology of the 
focal adhesion change.  First, small focal adhesions form at the leading edge of the cell in 
lamellipodia, structures that are made of integrin and adapter proteins, such as talin and 
paxillin
37, 297
.  Focal adhesions turn into larger and stable complexes, which in turn are 
able to recruit more proteins, such as zyxin
52
.  Then focal adhesions remain adhered to 
the ECM and the cell uses them as anchors on which it can pull or push itself over the 
ECM
53
.   Due to this constant alternation of adhesion and de-adhesion during the 
migration process, the cell is required to constantly adjust the strength of adhesion to the 
ECM, and substratum
52, 102
.  This process is also employed by the cell to mediate its 
adhesion when growth factors, such as the EGF, are stimulated
292
.  Therefore, it is 
plausible to propose that enhanced cell motility that is associated with the overexpression 
of EGFR
292-293
 is caused by the alterations in the capability of the cell to restructure its 
focal adhesions.   
Conventional methods to study the dynamic restructuring of focal adhesions 
require the use of fluorescent labels that are tagged on cellular structural and signaling 
components in fixed cells.  This type of method is known as end-point detection and it 
cannot reveal the details of the cellular response.  Incorporating fluorescent labels may 
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create a non-native and physiologically irrelevant cellular environment, thus leading to 
unclear results
23-24, 298
.   A study  by Denholm and coworkers demonstrated that using 
fluorescent probes for labeling leukocytes had a significant effect on the chemotactic 
response and that inhibitory activity of these probes may not be detected when 
chemotaxis is quantified solely by automated methods
298
.  Another study done by Abbitt 
and coworkers investigated if cell adhesion and migrations of flowing leukocytes was 
modified when the cells were labeled with one of the following fluorescent dyes, acridine 
organce (AO), calcein-AM (C-AM), and rhodamine 6G (R6G).  Their results indicated 
that most of the effect of such dyes on cell adhesion was related to the dye concentration 
used.  For example, acridine orange did not seem to be a suitable dye for cell adhesion 
studies, while R6G and C-AM could be used at dose of ~10µg/ml23.         
Recent work by Chen et al.
270
 established that the time-dependent ∆D-response of 
MCF-10A cells is related quantitatively to the amount of focal adhesions during dynamic 
restructuring
270
.  Using a similar approach, the goal of this study is to  relate the EGF-
induced restructuring of focal adhesions in MCF-10A cells and MCF-10A-EGFR cells
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in quantitative terms using data attained from the ∆D-response.  The number of EGF 
receptors found in MCF-10A-EGFR cells is within the same range of EGF receptors 
found in various breast cancer cell lines such as MCF-7 (1.2 x 10
4
 EGFR/cell), MDA-468 
(1.9 x 10
6
 EGFR/cell), and MDA-157 (1.0 x 10
4
 EGFR/cell)
300
.   The MCF-10A-EGFR 
cells overexpressed EGFR and they show a real-time ∆D-response profile different from 
that of the MCF-10A cells, which have a lower level of EGFR.  The detected differences 
in kinetics between both cell lines show that the overexpression of EGFR modifies the 
ability of cells to restructure their focal adhesions, which in turn may lead to enhanced 
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cell motility.  This study establishes the temporal resolution and sensitivity of the 
dissipation monitoring of the QCM-D (∆D) in quantitative kinetic assessment of the 
complex dynamic cellular process of cell adhesion.  
5.2 Methods 
5.2.1 QCM-D measurements 
A QCM-D (E4, Q-Sense) was used to record the changes in ∆D as a function of time with 
the order of overtone, n = 3.  The sensors were prepared as described in chapter 4.  The 
identical behavior of the MCF-10A-EGFR cells on both gold-surfaced and glass-surfaced 
crystals permit us to compare the ∆D-responses of the cells on gold-surfaced crystals 
with fluorescence images of the cells seeded on glass-surfaced coverslips.  Once the cells 
reach 95 % confluence, and they have been starved for 18 h, the cells were treated with 
assay buffer for 1 h to attain a stable baseline and finally the cells were treated with a 
solution of assay buffer containing EGF.  The ∆D-responses were recorded continuously 
at 37 
o
C for 3 h.  The Δf-responses were also recorded but, unlike the ΔD-responses, 
showed no measurable response and no sensitivity to dose.    Refer to chapter 4 for a 
detailed description of QCM-D measurements.         
5.2.2 Data analysis 
Dose-response curves were generated by plotting the average amplitudes (±1 std. 
dev) of the ∆D-response as a function of EGF concentrations.  The amplitude was 
defined as the difference between the experimental value and the control value (0 nM 
EGF); the absolute value for the amplitude was taken at 40min of the ∆D-response.  The 
EC50 value was determined by fitting the data to the following equation: 
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              5.1 
Where x is the concentration of the ligand and a is the maximum ∆D-response, 
which can be determined through curve fitting.  The EC50 value was calculated from the 
curve fitting with the aid of PSI-Plot (Poly Software International).  
The kinetic analysis was carried out by fitting the ∆D-response curves with an 
empirical model that consists of a combination of a single exponential and a linear 
function: 
CtkeAD
tk   21
1                   5.2                                                     
Where k1 is the time constant for the initial decline and k2 is the relaxation time constant 
of the late rise.  A1 is the amplitude and C is the fitting constant.  This empirical model 
serves to explain the rate constant of the ∆D-response. 
5.3 Results and Discussion 
 In this study, the QCM-D was used to quantitatively evaluate the EGF-induced 
∆D-responses of confluent monolayers of non-tumorigenic human epithelial breast MCF-
10A cells and MCF-10A-EGFR
299
.  Both of these cell lines were picked for this study 
because they behave very similar to cancerous cells.  In order to validate that the results 
obtained were reliable and accurate, each QCM-D experiment was repeated with cells 
from different cell cultures at least three times.   
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5.3.1 EGF-induced response ∆D-responses of MCF-10A cells and MCF-10A-
EGFR cells 
To describe EGF-induced ∆D-responses of MCF-10A cells, the responses of the 
cells treated with a range of concentrations of EGF were examined (Figure 5.1A).  As the 
concentration of the EGF increased, the level of the ∆D-response increased as well.  
Figure 5.1A shows that the MCF-10A cells treated with EGF display an initial sharp 
increase in ∆D-response; this is due to mechanical perturbation of the cells during liquid 
transfer by pipetting.  After this initial spike, the ∆D-response curve shows a rapid 
decline that continues for about 30 min.  Chen et al. described a similar pattern when  
they used MCF-10A cells in their studies
270
.  After the 30 min had passed, the rate of this 
decline begins to decrease until the ∆D-response curve reached a minimum point after 
approximately 60 min.  Then the ∆D-response curve starts to rise slowly for the 
remainder of the experiment, ~90 min. 
This trend is also observed when MCF-10A-EGFR cells were challenged with the 
same concentrations of EGF (Figure 5.1B).  Figure 5.1B shows the ∆D-response curve of 
MCF-10A-EGFR cells.  The rapid decline of the ∆D-response observed is faster than the 
one observed for MCF-10A cells, which is around 20 min.  After approximately 20 min, 
the ∆D-response declines some more until the curve had reached its lowest point at about 
40 min and the ∆D-response remains flat for about 20 more min.  After 60 min, the ∆D-
response begins to slowly increase for the remainder of the experiment.  These results 
indicate that the MCF-10A-EGFR cells have a stronger and quicker ∆D-response to EGF 
compared to the MCF-10A cells.  This can be attributed to the fact that the MCF-10A-
EGFR cells overexpressed EGFR
299
. 
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Figure 5.1:  Real-time QCM-D measurements (at the order of overtone n = 3) of the ∆D-responses of MCF-10A cells 
at 37 oC.  The ∆D-responses of MCF-10A cells at the following EGF concentrations: 0, 1, 5, 10, 20 and 40 nM.  B  The 
∆D-responses of MCF-10A-EGFR cells at the following EGF concentrations: 0, 1, 5, 10, 20 and 40 nM301. 
 
5.3.2 Comparison of the half maximal effective concentration (EC50) value 
between MCF-10A and MCF-10A-EGFR cells 
To further assess the dose dependency of both MCF-10A cells and MCF-10A-
EGFR cells, an EC50 curve was created by plotting the average amplitude of the ∆D-
response value for MCF-10A cells and MCF-10A-EGFR cells at 60 and 40 min 
respectively as a function of EGF concentration, and then we fitted equation 5.1 (p. 59) to 
the aforementioned data to calculate the corresponding EC50 values.  An EC50 value of 
1.2 ± 0.5 nM was attained from the curve-fitting of the MCF-10A cells (Figure 5.2A) and 
an EC50 value of 2.2 ± 1.2 nM was attained for the MCF-10A-EGFR cells (Figure 5.2B).  
The student t-test (two-tailed) of these values shows that 0.40 < p < 0.60, indicating that 
there is no statistically significant difference between the behavior of the two samples.  If 
the EC50 is used as an approximate measure of binding affinity
302
, the MCF-10A-EGFR  
cells have about the same EGF-binding affinity  as the MCF-10A cells.  These values are 
within the reported range of kd values for EGFR, (kd ≤ 1 nM)
303
.  
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Figure 5.2:  Average amplitude (± std. dev.) of the ∆D-response as a function of EGF concentration.  The data was fit 
using equation 5.1.   A:  EC50=1.2 ± 0.5 nM for MCF-10A cells data taken at 60 min.  B:  EC50= 2.2 ± 1.2 nM for 
MCF-10A-EGFR cells data taken at 40 min301. 
 
5.3.3 Kinetic assessment of the restructuring of focal adhesions in MCF-10A cells 
A side-by-side comparison of the EGF-induced ∆D-response of MCF-10A cells 
and MCF-10A-EGFR cells was needed to further understand the ∆D-response of each 
cell line when treated with EGF (Figure 5.3A).  Both cells lines were stimulated with 10 
nM EGF at 37 
o
C, and the resulting ∆D-responses were recorded with the QCM-D at the 
order of overtone n = 3.  After the addition of EGF, both ∆D-responses show the sharp 
upward spike previously described as the result of the mechanical perturbation of the 
cells due to the addition of the EGF solution via pipetting.  After the initial spike, both 
∆D-responses declined rapidly, in fact the ∆D-response of the MCF-10A cells reached -
40 x 10
-6
 units in about 46 min, while for MCF-10A-EGFR cells the ∆D-response 
reached the same number of units in less time, 26 min.  After the initial decline, the ∆D-
responses of both the MCF-10A cells and MCF-10A-EGFR cells flattened out around 60 
min.  After this time, the ∆D-response of the MCF-10A-EGFR cells remained relatively 
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steady during the remainder of the 170 min measurement, whereas the MCF-10A cells 
steadily increased for the remainder of the experiment. 
 
 
Figure 5.3 A:  The time-dependent EGF-induced ∆D-responses (at the order of overtone n = 3) of MCF-10A cells and 
MCF-10A-EGFR cells at 37 oC.  The variances between the MCF-10A cells and MCF-10A-EGFR cells were the 
results of repeated experiments.  B:  the time-dependent ∆D-responses were fit to equation 5.2 to determine the kinetic 
parameters described in Table 5.1301.     
 
To understand the behavior of the MCF-10A cells and MCF-10A-EGFR cells 
after EGF stimulation, a quantitative kinetic assessment was performed by fitting the ∆D-
response curves to an empirical model in equation 5.2 (p. 60), which contains a 
combination of a single exponential and a linear function.  The curve-fitting results are 
shown in Figure 5.3B and the estimated rate constants are summarized in Table 5.1. 
Table 5.1:  The rates (±1 std. dev.) were determined by fitting the ∆D-response curves to Eq. 5.2.  The rates diverged in 
repeated experiments, but the overall trend that the MCF-10A-EGFR cells portrayed was an accelerated disassembly 
and decelerated reassembly of focal adhesions, which was observed in all experiments301.     
 Rate constant of the initial 
decline (k1, min
-1
) 
Rate constant of the late 
rise          (k2, min
-1
) 
MCF-10A 0.056 ± 0.002 0.29 ± 0.007 
MCF-10A-EGFR 0.22 ± 0.026 0.047 ± 0.008 
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 Chen et al. showed that the decline of the EGF-induced ∆D-response corresponds 
to the disassembly of focal adhesions
270
, the approximately fourfold difference in the rate 
constant between the MCF-10A cells and MCF-10A-EGFR cells suggests that the focal 
adhesions of MCF-10A-EGFR cells undergo a faster disassembly than those of the MCF-
10A cells.  Since the level of focal adhesions is quantitatively related to the strength of 
cell adhesion
304-307
, the EGF-induced disassembly of focal adhesions results in weaker 
cell adhesion, enhancing the likelihood of the cell to detach and migrate.   A study done 
by Lu and coworkers
293
 suggests that A431 cells that overexpress EGFR undergo rapid 
destruction of focal adhesions and rapid detachment from the substrate after EGF 
stimulation, which in turn results in increased cell motility and invasiveness.  The results 
from this study are consistent with our findings. 
The increase in ∆D-response relates to the reassembly of focal adhesion, a more 
than sixfold difference in the rising rate constant between both cell lines used in our study 
(Table 5.1), suggests that MCF-10A cells recover more quickly from the initial de-
adhesion to re-adhere to the substrate through reassembly of focal adhesions, which is 
due to the lower levels of EGFR present.  By contrast, having an overexpression of 
EGFR, the focal adhesions in the MCF-10A-EGFR cells, took a longer time to 
reassemble than those in the MCF-10A cells, which permitted the MCF-10A-EGFR cells 
to keep a weakly adherent state for a much longer period of time, long after EGF-
stimulation.  As a result, this weakly adherent state could be a more favorable state for 
continuous migration.  The findings of this study correlate with the observation by 
Kruger et al.,
308
 which showed that breast cancer MCF-7 cells, which express low levels 
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of EGFR, show only a temporary migratory capability after growth factor stimulation, 
while EGFR-overexpressing MCF-7 cells exhibited enhanced and continuous migration. 
5.3.4 Examining focal adhesions through immunofluorescence imaging 
In order to validate the results obtained from the QCM-D study, a more traditional 
biological assay was used.  We used immunofluorescence imaging to examine the 
restructuring of focal adhesions in MCF-10A-EGFR cells.  The images of the focal 
adhesions of the EGF-treated MCF-10A-EGFR cells at various time points are shown in 
Figure 5.4A to E.  These images show the following: an initial sharp decrease in the level 
of focal adhesions from 0 to 30 min, then a less rapid decrease from 30 to 60 min, and 
finally a reasonably steady level between 60 and 150 min.  The qualitative observations 
were further confirmed with quantitation based on the areal density of the immunostained 
vinculin (Figure 5.4F).  Although these results correlate with the kinetic profile attained 
from the QCM-D measurements (Figure 5.3), this traditional method is not ideal if a 
quantitative assessment of the kinetics of the restructuring of the focal adhesions is 
needed, this is because the uncertainty associated with the selection of the time points and 
the lack of the real-time data, which is significant for determining the rate constants with 
curve-fitting.  
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Figure 5.4:  Restructuring of focal adhesions in MCF-10A-EGFR cells.  The images of focal adhesions in a monolayer 
of MCF-10A-EGFR cells after being exposed to 10nM EGF at different times:  a:  0 min, b:  30 min, c:  60 min, d:  100 
min, and e:  150 min.  Immunostained vinculin was used to indicate the levels of focal adhesions observed.  Arrows 
were used to point focal adhesions in the image, the scale bar is 10µM.  f:  Quantitation of the areal density of focal 
adhesions in relative fluorescence units (RFU) (mean ± SEM; n = 10 cells)301. 
 
5.3.5 Comparison of the EGF-induced ∆D-response between a gold and a glass 
sensor  
Since the QCM-D experiments were all performed on gold-covered sensors and 
the immunofluorescence ones were completed on glass cover slips, it was important to 
validate the results obtained from both methods.  We decided to grow MCF-10A cells 
and MCF-10A-EGFR cells on gold-and glass (silicate)-covered sensors using the same 
method described in chapter 4 in the cell culture methods.  The QCM-D experiment was 
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run side-by-side, where the cells were stimulated with 10 nM EGF and the curves 
obtained were plotted on the same graph (Figure 5.5).   
 
Figure 5.5:  Real-time QCM-D measurements (at the order of overtone n = 3) of the ∆D-response of MCF-10A cells at 
37 oC.  A:  Side-by side comparison of the ∆D-response of  MCF-10A cells seeded on two different sensors: glass (red) 
and gold (black) after 10 nM EGF stimulation.  B:  Side-by-side comparison of the ∆D-response of MCF-10A-EGFR  
cells seeded on two different sensors: glass (yellow) and gold (blue) after 10 nM EGF stimulation.  Experiments were 
repeated at least three times.  
 
Based on the results obtained, we concluded that the type of surface on the sensor 
used has a negligible impact on the EGF-induced ∆D-response, thus corroborating the 
utilization of the immunofluorescence experiment, where glass cover slips were used.        
5.4 Conclusion   
The amount of receptors and ligands expressed on tumor cells will have an effect 
on the quality and quantity of EGFR signaling within cancer cells
309-310
.  Elevated levels 
of EGFR can alter the cell’s ability to restructure their focal adhesions; nevertheless, it 
remains to be demonstrated how the elevated levels of EGFR can cause such alterations.  
It has been previously shown that elevated levels of EGFR causes changes in cell 
signaling
120, 293, 308, 311
 and we theorize that alterations in the cell’s ability to restructure 
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focal adhesions are probably a direct result of the change in the downstream signaling 
pathways of EGFR.  
This side-by-side comparative study between MCF-10A cells and MCF-10A-
EGFR cells using the QCM-D demonstrated that after EGF-stimulation, the MCF-10A-
EGFR cells, which expressed higher levels of EGFR, showed an increase in the rate of 
the initial disassembly and a decrease in the rate of the reassembly of focal adhesions 
compared to the MCF-10A cells, which as previously stated, expressed a lower level of 
EGFR.  Our findings suggest that the altered rates of the restructuring of focal adhesions 
in the MCF-10A-EGFR cells may stimulate the initiation and maintenance of a optimun 
adhesion state for cell migrations. 
In this study, we have established that the dissipation monitoring function of the 
QCM-D technique is capable of quantitatively assessing the kinetic aspects of an 
important cellular process like cell adhesion.  Owing to the QCM-D technique’s non-
invasiveness to mammalian cells
265
, it is preferable for determining the kinetics of cell 
adhesion compared to techniques that involve invasive forces or non-native dyes or 
particles.  Label-free technologies, like the QCM-D, can provide high spatial resolution 
to resolve the location, trafficking, and organization of signaling molecules within a 
specific pathway.  Although label-based assays can study the interactions among different 
signaling molecules, they often give rise to low temporal resolution and are weak in 
resolving cell-surface biology. In addition, the temporal resolution and sensitivity of the 
QCM-D demonstrated in this work provides real-time kinetic measurement of cell 
adhesion.  This suggests that this label-free mechanical sensor approach has great 
potential to investigate the entire process of various cell signaling and cellular processes 
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in native cells without modifying or destroying the living cells. Some of the possible 
applications where QCM-D could be used include cell biology studies, such as cell 
signaling, trafficking, and mechanotransduction.      
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Chapter 6: Inhibition of the EGF-induced response of MCF-10A-EGFR cells 
6.1 Introduction 
The EGFR regulates cell growth, proliferation, motility and differentiation through 
its downstream signaling pathways
288-289
.  The main pathways that are activated when 
EGF binds to the extracellular domain of EGFR are the mitogen-activated protein 
kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway
312
, the 
phosophoinositide 3-kinase (PI3K) pathways
313
, and the phospholipase C (PLC) 
pathway
292
.  The regulation of these downstream signaling pathways can be altered when 
there is an abnormality in the EGFR system, such as overexpression and/or mutation of 
the EGFR, downregulation of EGFR or increased production of ligands like EGF, thus 
leading to the development of cancers
314-315
.      The understanding of the effects of such 
abnormalities in the EGFR system can help us have a better understanding of the role that 
these abnormalities have in cancer development, which in turn, can contribute to 
developing a  better way to cancer diagnosis, treatment and prognosis
21
. 
In this work, we used the QCM-D technique to study cellular responses to EGFR.  
This type of technology is able to provide integrated and phenotypic readout at the whole 
cell level
316
.  As mentioned in previous chapters, label-free sensor technologies based on 
either optical or non-optical sensing platforms are for the most part non-invasive to cells 
and they are also capable of providing real-time measurement of cell signaling kinetics 
with high temporal resolution and sensitivity
183, 317
.  Some examples of optical and non-
optical, label-free sensing platforms are described in more detail in chapters 1 and 2.  The 
benchmark technology among these non-optical platforms is electrical impedance, which 
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is important because it uses its sensitivity to ionic movement under electric fields to 
indicate morphological changes in a layer of cells
157
.       
The quartz crystal microbalance with dissipation monitoring (QCM-D) has become 
a popular technique in the field of cell biology due to its ability to monitor the interaction 
between cells and the surface to which they are attached, as well as to determine the 
kinetics of cell attachment and spreading
27, 263-264
.  In one of our studies we used the 
QCM-D technique to measure the short-term responses of human epidermoid carcinoma 
A431 cells to EGFR-mediated signaling based on real-time monitoring of changes in the 
dissipation factor (∆D) and frequency responses (∆f)266.  Chapter 5 described the ability 
of the QCM-D technique to measure the responses of both MCF-10A cells and MCF-
10A-EGFR cells during EGF-induced cell de-adhesion, which is the opposite to cell 
adhesion
270, 301
.  In this study, a relationship between the time-dependent ∆D-response of 
the QCM-D and the level of focal adhesions of the cells was established
270, 301
.  Due to 
the findings of this particular study, we examined the regulation of the dynamic de-
adhesion process by studying the EGFR downstream signaling pathways, including the 
PI3K, MAPK/ERK, and PLC pathways
270, 301
.  These pathways are described in more 
detail in chapter 1.   
The work presented here describes a study of the EGF-induced de-adhesion of 
MCF-10A-EGFR cells from the surface to which they are attached.  Compared to MCF-
10A cells, the MCF-10A-EGFR cells have a higher level of EGFR
299
, a condition that 
resembles the abnormal levels of EGFR in many types of solid tumors
291
.  As previously 
stated, such abnormalities have been linked to dysregulated cellular functions, such as 
cell adhesion, which is a significant cellular process
45, 318
.  The malfunction which 
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promotes tumor invasion and metastasis
8, 314
.  Being able to find a way to effectively 
suppress tumor migration by inhibiting the EGF-induced cell de-adhesion might help in 
the development of a more effective way to treat cancer.  The main focus of this study 
was to evaluate the inhibition of the EGF-induced de-adhesion in MCF-10A-EGFR cells.  
The QCM-D was used to track the real-time EGF-induced de-adhesion of MCF-10A-
EGFR cell and to measure the real-time responses of cells during this complex process.  
This study shows that the EGF-induced cell de-adhesion can be altered by various 
inhibitors of the signaling pathways (PD158780 for the EGFR activation, LY294002 for 
the PI3K pathway, U73122 for the PLC pathway and L-779450 for the MAPK/ERK 
pathway), and cytoskeleton formation (cytochalasin D for actin polymerization) in a 
dose-dependent manner.  The effectiveness of each inhibitor, determined by QCM-D, 
corresponds well with the value reported in the literature.  This strong relationship 
suggests that the QCM-D has the capability to become an effective sensing technique for 
screening therapeutic agents that can target signaling and cytoskeletal proteins.           
6.2 Methods 
6.2.1 QCM-D measurements 
A QCM-D (E4, Q-Sense) was used to record the changes in ∆D as a function of 
time with the order of overtone, n = 3.  The sensors were prepared as described in chapter 
4.  The identical behavior of the MCF-10A-EGFR cells on both gold-surfaced and glass-
surfaced crystals permit us to compare the ∆D-responses of the cells on gold-surfaced 
crystals with fluorescence images of the cells seeded on glass-surfaced coverslips.  Once 
the cells reached 95 % confluence, and they had been starved for 18 h, the cells were 
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treated with assay buffer for 1 h to attain a stable baseline, and the cells were then 
incubated in the inhibitor solution at 37 
o
C for 40 min.  Then the inhibitor solution was 
replaced with a solution of 10 nM EGF in the assay buffer containing the same 
concentration of the inhibitor and the cells were incubated for 3 h.  The Δf-responses 
were also recorded but, unlike the ΔD-responses, showed no measurable response and no 
sensitivity to dose. Refer to chapter 4 for a detailed description of QCM-D 
measurements.      
6.2.2 Data analysis 
Dose-response curves were generated by plotting the average amplitudes (±1 std. 
dev) of the ∆D-response versus inhibitor concentrations.  Each amplitude value was 
defined as the difference between the experimental value and the control value; the 
absolute value for the amplitude was taken at 40 min of the ∆D-response.  The half 
maximal inhibitory concentration (IC50) value was determined by fitting the data to the 
following equation, 
xIC
ax
D


50
         6.1 
 Where x is the concentration of the inhibitor, a corresponds to the maximum ∆D-
response, which can be determined through curve fitting.  The use of the log functional 
plot or sigmoid plot for this analysis would not significantly alter the resulting IC50 
values.    
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6.3 Results and Discussion     
In chapter 5 we described a way to use the QCM-D to track the EGF-induced 
cellular responses of confluent monolayers of human nontumorigenic epithelial breast 
MCF-10A cells.  The results indicated that the time-dependent ∆D-responses measured 
by the QCM-D were found to be correlated with dynamic changes in the areal density of 
the focal adhesions of the cells.  Due to the fact that the areal densities of focal adhesions 
is quantitatively related to the strength of cell adhesion
304-307
, we used the ∆D-response as 
an indicator of the strength of cell-substrate adhesions to determine the EGF-induced cell 
de-adhesion in MCF-10A cells.  These results indicated that the cells exhibit a complex 
de-adhesion process, involving de-adhesion, transition, and re-adhesion.  In that study, as 
in the one presented here, we used various inhibitors to control the EGF-induced ∆D-
responses in order to gain an understanding of the mechanisms governing the regulation 
of cellular responses.  
The screening of molecular interactions involving the determination of the affinity, 
activity and toxicity of a drug is an important part of the drug discovery process.  The 
majority of the techniques currently employed to study bio-molecular interactions require 
some type of radio- or enzymatic- or fluorescent-labelling to report the binding of the 
ligand to its receptor
23-24, 298
.  This labelling step can interfere with the molecular 
interaction by obstructing a binding site leading to false negatives.  Most label-dependent 
screening platforms are based on the measurement of fluorescence or radioactivity
319-321
.  
These are powerful technologies that allow rapid determination of the affinities and even 
the kinetics of a drug-receptor interaction with high sensitivity.  However, there are an 
increasing number of novel-techniques that do not require labelling of the ligand or the 
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receptor, and that permit any complex to be screened with minimal assay development.  
Currently, there are three major label-free screening platforms: optical, calorimetric, and 
acoustic sensors.  These label-free technologies have the potential to deliver high quality, 
high information content screening. 
Optical sensors are often referred to as affinity-based sensors
322
.  They are able to 
directly detect the binding of small molecules to immobilized receptors, thus making 
them good candidates for drug screening
184
.  Among the most common optical sensors 
are SPR
271-272
, ellipsometry
272-273
, RM
274
, reflectometric interference spectroscopy
275
.  All 
of these four techniques have been previously described in detail in chapter 2.  On the 
other hand, calorimetric sensors are considered the “gold standard” technique for 
characterizing the thermodynamics and stoichiometry of a molecular interaction
323
.  
Isothermal titration calorimetry (ITC) is a well-known calorimetry technique used in 
many areas of pharmaceutical analysis to measure the heat that is either generated or 
absorbed when substances bind to each other
323
.  Measurement of this heat allows the 
determination of binding constants, reaction stoichiometry and the thermodynamic profile 
of the interaction
324
.  ITC does not require immobilization and/or modification of the 
reactants since heat of binding is a naturally occurring phenomenon.  Unfortunately, 
applications of ITC in the pharmaceutical industry have been limited because this 
technique requires large amounts (>µmolL-1) of the receptor and ligand and also by the 
limited throughput available on commercial instrumentation
323-324
.  Finally, acoustic 
sensors allow the label-free detection of molecules and analysis of binding events
183
.  A 
well-known acoustic sensor is the QCM-D, which has been described in great extent in 
this thesis work.                            
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The study described in this chapter, shows a method to assess the potential of using 
the QCM-D as a sensing platform for drug screening.  It is important to note, that due to 
the limited throughput of the QCM-D, where only four independent experiments can be 
run at the same time, the QCM-D is still far from ready for drug screening.  Therefore, 
the main focus of this study is on sensitivity and reliability.  The first part of this study 
evaluates the dose response for inhibition of the EGF-induced cell de-adhesion process in 
MCF-10A-EGFR cells that overexpress EGFR.  This cell line was selected for this study 
because they behave like cancerous cells and also because they overexpress EGFR.  In 
the second part, we verified the time dependence of the inhibition with 
immunofluorescence imaging.  The last part of this study was aimed at determining the 
potency of each inhibitor and compares its experimental value with the literature value.  
All QCM-D experiments were conducted at 37 
o
C, stable baselines were established 
before the addition of each inhibitor.  Six to seven concentrations of each inhibitor were 
carefully selected, which cover the ranges that permit the attainment of sensible dose-
response curves and reliable IC50 values.  We minimize the impact of the usual variations 
observed from cell-based assays by running QCM-D experiments with cells from at least 
three different cultures and fluorescence imaging experiments with cells from two 
separate cultures.  Furthermore, carefully designed control experiments were performed 
under individual conditions.  Finally, for the dose response studies, the variations did not 
considerably alter the determination of IC50 values        
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6.3.1 QCM-D measurements:  Inhibition of the EGF-induced time-dependent 
cellular responses  
Figure 6.1 shows the results of a dose-response inhibition of the EGF-induced 
cellular response measured with the QCM-D.  In this experiment, we used PD158780, 
which is a potent inhibitor of EGFR tyrosine kinase
325
.  Seven different doses of 
PD158780 (0, 10, 20, 50, 100, 200 and 400 nM), were introduced into confluent 
monolayers of MCF-10A-EGFR cells on QCM-D sensor crystals.  Each inhibitor was 
incubated at 37
o
C for 40 min, after this time, each solution was replaced with a 10nM 
EGF solution.  The ∆D-responses at overtone, n = 3, were recorded at 37 oC for 3 h.  Just 
as in our previous studies, we only focus on the ∆D-responses because it is a more 
sensitive measure of the EGF-induced cellular responses than the ∆f-responses270.   
Also, in Figure 6.1, the ∆D-response curve that is labeled 0 nM represents the 
time-dependent profile of MCF-10A-EGFR cells responding to 10 nM EGF without the 
presence of the inhibitor.   After the addition of EGF, the ∆D-response curve shows a 
sharp upward spike, which is the result of the mechanical perturbation caused by adding a 
liquid to the cell layer.  After this initial spike, the ∆D-response curve shows a fast 
decline that continues until ~25 min; this phase corresponds to a rapid cell de-adhesion.  
After ~40 min, the observed rate of this decline starts to diminish until the valley of the 
∆D-response is reached at ~65 min.  For the next 15 to 20 min, the response curve stays 
constant.   This time period between 40 to 80 min is determined to be the transition phase 
of the ∆D-response.  After this transition phase, there is a slow but steady increase in the 
∆D-response for the next 80 min; a phase indicative of cell re-adhesion.  The response 
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profile usually observed in MCF-10A-EGFR cells shows a more rapid de-adhesion and a 
slower re-adhesion compared to the MCF-10A cells
270
.  
 
Figure 6.1:  Real-time QCM-D measurements (overtone n = 3) of the ∆D-responses of MCF-10A-EGFR cells to 10 nM 
EGF at 37 oC.  The ∆D-responses of the cells were suppressed by PD158780, a potent inhibitor of EGFR tyrosine 
kinase, at various doses (0, 10, 20, 50, 100, 200 and 400 nM)326.  
 
   
 In the presence of the inhibitor, PD158780, the amplitude of each EGF-induced 
∆D-response curve was significantly reduced, and the higher the concentration of the 
inhibitor the greater the decrease of the amplitudes of the EGF-induced ∆D-response.  At 
the two highest concentrations, 200 and 400 nM, the EGF-induced ∆D-responses were 
totally abolished, as shown in Figure 6.1, where their amplitudes are close to zero.  All of 
these notable changes to the EGF-induced ∆D-responses indicate an essential role of the 
EGFR tyrosine kinase in regulation of cell-adhesion. 
 The results of the next experiment are shown in Figure 6.2. It explored the 
inhibitory effect of Cytochalasin D (CD) on the EGF-induced ∆D-response.   
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Cytochalasin D is a potent, cell permeable inhibitor of actin polymerization and it is 
capable of weakening the remodeling of the actin filaments
327
.  Pretreating the cells with 
CD substantially suppresses the EGF-induced ∆D-response, confirming that the 
cytoskeleton remodeling is related to the observed ∆D-response to EGF.  This 
observation, indicates a connection between the cytoskeleton remodeling and cell 
signaling and trafficking
328-329
.  
 
Figure 6.2:  Real-time QCM-D measurements (overtone n = 3) of the ∆D-responses of MCF-10A-EGFR cells to 10 nM 
EGF at 37 oC.  The ∆D-responses of the cells were suppressed by Cytochalasin D, a known inhibitor of actin 
polymerization, at various doses (0, 0.1, 0.3, 0.6, 1, 2, and 4 µM)326.  
 
  
In Figures 6.3 to 6.5, the results of the inhibition of the EGFR downstream 
signaling pathways are shown.  The EGFR downstream signaling pathways include the 
MAPK/ERK, PI3K and PLC pathways.  All of these pathways are responsible for 
controlling the assembly and disassembly of focal adhesions that lead to changes in cell 
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adhesion
127, 133, 330
, thus making them targets for therapeutic development in recent 
years
331-333
.  In order to investigate the role of these pathways in more detail, we 
pretreated the cells with L779450
334
, which is a potent cell-permeable inhibitor of Raf 
Kinase in the MAPK/ERK pathway. We also used LY294002
335
, a potent inhibitor of 
PI3K in the PI3K pathway
335, and finally U73122, which is a potent inhibitor of PLCγ 
(an isotype of phospholipase) in the PLC pathway
336
.  The results depicted in Figures 6.3 
to 6.5 clearly reveal that the EGF-induced ∆D-responses are altered by the inhibitors in a 
dose-dependent manner.  The amplitudes of the EGF-induced ∆D-responses for both 
L779450 (Fig. 6.3) and LY294002 (Fig. 6.4) were greatly reduced, suggesting that the 
MAPK/ERK and PI3K pathways are responsible for promoting the EGF-induced cellular 
response in MCF-10A-EGFR cells.   
 
Figure 6.3:  Real-time QCM-D measurements (overtone n = 3) of the ∆D-responses of MCF-10A-EGFR cells to 10 nM 
EGF at 37 oC.  The ∆D-responses of the cells were suppressed by L779450, a known inhibitor of Raf Kinase in the 
MAPK/ERK pathway, at various doses (0, 0.1, 0.5, 5, 8, and 10 µM)326.         
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Figure 6.4: Real-time QCM-D measurements (overtone n = 3) of the ∆D-responses of MCF-10A-EGFR cells to 10 nM 
EGF at 37 oC.  The ∆D-responses of the cells were suppressed by LY294002, a potent inhibitor of PI3K in the PI3K 
pathway, at various doses (0, 0.5, 1, 3, 5, 8, and 10 µM)326.  
 
    
These results further confirm previous reports that show that the MAPK/ERK 
pathway is responsible for the EGF-induced disassembly of the focal adhesion in 
fibroblasts and the PI3K pathway may alter cell adhesion through its downstream 
effectors including small GTPase Rho A, and/or through crosstalk with the MAPK/ERK 
pathways.  Interestingly, we observed that the U73122 inhibitor increased rather than 
reduced the amplitudes of the EGF-induced ∆D-responses (Figure 6.5), thus suggesting 
an enhanced cell de-adhesion upon the inhibition of the PLC pathway, a pathway known 
to play an important role to EGF-mediated cell adhesion and motility
120
. 
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Figure 6.5:  Real-time QCM-D measurements (overtone n = 3) of the ∆D-responses of MCF-10A-EGFR cells to 10 nM 
EGF at 37 oC.   The ∆D-responses of the cells were increased by U73122, a known inhibitor of PLCγ in the PLC 
pathway, at various doses (0, 0.5, 1, 5, 8, and 10 µM)326. 
 
     
 What is interesting about these findings is that the inhibition of each pathway led 
to very different features of the time-dependent dose response profiles, as shown in 
Figures 6.3-6.5.  For example, when the MAPK/ERK pathway was inhibited by 
L779450, the parts of the EGF-induced response curves corresponding to the initial rapid 
de-adhesion (first 20 min) remained very close to each other for most inhibitor 
concentrations (Figure 6.3).  On the contrary, all the inhibitory response curves were well 
separated from each other during the same period of time (first 20 min) when LY294002 
was used to inhibit the PI3K pathway (Figure 6.4).  These specific features of the 
inhibition profiles can be described as the “signatures” of the cellular response of 
individual pathways, like a unique form of the pathway-dependent phenotypic 
response
322, 337-338
.  All of these signatures can be used in future studies as a way to 
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provide mechanistic insights into the regulation of the EGF-induced cell de-adhesion in 
MCF-10A-EGFR cells.   
6.3.2 Fluorescence Imaging:  Inhibition of the EGF-induced time-dependent 
cellular responses 
Thus far we demonstrated the capability of label-free sensors to produce real-
time, measurable signals by measuring specific time-dependent cellular responses.  Such 
signals often result from more than one of various changes that relate to cellular 
morphology, adhesion, ion distribution, and mass distribution
183-184, 338
.  Since all of these 
signals are a result of the collected effects inside the cell, it becomes difficult to identify 
individual contributing molecular components and their related cellular processes.  Thus, 
label-free sensor signals are often referred to as “black box” assay readouts339.  
Chapter 5 described the quantitative relationship between the ∆D-response 
obtained from the QCM-D and the level of focal adhesions, which were determined with 
measurements of the areal density of immunostained vinculin
301
.  In the work described 
in the present study, we used a similar strategy to verify the effect of each inhibitor on 
MCF-10A-EGFR cells and further establish the link between the time-dependent ∆D-
response and the restructuring of focal adhesions.   
In a first step, we determined the effect of each inhibitor on EGF-induced changes 
with regard to the level of focal adhesions.  Figures 6.6B to 6.6G show the fluorescence 
images of immunostained vinculin within focal adhesions of MCF-10A-EGFR cells.  
Images were taken from cell samples that had been previously pretreated with the 
particular inhibitor for 40 min (or the assay buffer for the control) and then exposed to 10 
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nM EGF for 60 min.  The comparison based on the quantitation of fluorescence 
intensities of stained vinculin is shown in Figure 6.6A. When the inhibitors PD158780 
(100 nM Figure 6.6C), cytochalasin D (1 µM, Figure 6.6D), L779450 (10 µM, Figure 
6.6E), and LY294002 (10 µM, Figure 6.6F) are present, the cells exhibit slightly higher 
fluorescence intensities of vinculin compared to the control cells, which were not 
subjected to inhibitors (Figure 6.6B).  These results show that the investigated inhibitors 
enhanced cell adhesion by suppressing the EGF-induced de-adhesion, which is consistent 
with the observed reduction of the amplitudes of the ∆D-responses in Figures 6.6A to 
6.6D. Interestingly, the sample that had been pre-treated with 5 µM U73122 (Figure 
6.6G) exhibits a slightly lower fluorescence intensity compared to the control (Figure 
6.6B), a result that is consistent with the increasing amplitudes of the ∆D-responses of the 
MCF-10A-EGFR cells in the presence of U73122 (Figure 6.6G), which is sign of an 
enhanced cell de-adhesion. 
 
 
 
 
 
 
89 
 
 
 
  
Figure 6.6:  Fluorescence images of immonostained vinculin within focal adhesions of MCF-10A-EGFR cells in 
response to 10 nM EGF.  The arrows indicate examples of focal adhesions.  Scale bar used:  10 µm.  The cells had been 
pretreated with an inhibitor described in (B-G).  (A) Shows the quantitation of the areal densitites of stained vinculin in 
relative fluorescence units (RFU) as a measure for the level of focal adhesions (mean ± SEM; n = 10) in (B-G).  (B) 
The control without the presence of any inhibitor.  (C) 100 nM PD158780.  (D) 1 µM Cytochalasin D.  (E) 10 µM 
L77945.  (F) 10 µM LY294002.  (G) 5 µM U73122.  The difference in fluorescence intensities (10 samples for each 
inhibition studied) between the control and each inhibited sample is significant as indicated by p < 0.001 for all five 
inhibited samples326. 
 
  
In a second step, we determined the time-dependent effect of each inhibitor by 
exploring concomitant changes in areal density of focal adhesions (Figure 6.7).  Figures 
6.7AC to 6.7AG show the fluorescence images of immunostained vinculin within focal 
adhesions of MCF-10A-EGFR cell that had been pretreated with 100 nM PD158780 and 
then exposed to 10 nM EGF for various times (0, 30, 60, 100 and 150 min).  It is 
important to note that due to the high fluorescence background, some of the images in 
Figure 6.7 look a lot brighter than others, although the intensities of immunostained 
vinculin in those images are not as high as the others.  Also, the appearance of dark holes, 
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which appeared to be enclosed within bright boundaries, was probably caused by 
immunostained vinculin at sites of cell-cell contact. 
Before exposing the cells to EGF (0 min), there are several prominent focal 
adhesions present, which can be seen as short bright streaks of vinculin in both the central 
regions and the peripheries of the cells that had been pretreated with 100 nM PD158780 
(Fig. 6.7AC).  After exposing the cells to 10 nM EGF for 30 min, the cells show fewer, 
smaller, and less intense spots of stained vinculin (Fig. 6.7AD), indicating a lower level 
of focal adhesions.  After 60 min, the exposure to 10 nM EGF further diminished the 
spots of stained vinculin in both size and number, Fig. 6.7AE.  A longer exposure to EGF 
(100 min) did not cause any further decrease of stained vinculin.  In fact, their appearance 
shows a slight increase in both size and number, which is an indication of an increased 
level of focal adhesions (Fig. 6.7AF).  After 150 min exposure to EGF, the stained 
vinculin spots (Fig. 6.7AG) become more visible compared to the 100 min exposure.  
Overall, exposing a monolayer of MCF-10A-EGFR cells to EGF causes them to undergo 
a time-dependent restructuring of focal adhesions, which corresponds to de-adhesion, 
transition and re-adhesion.  The pattern observed here is consistent with the one observed 
with the QCM-D measurements in Figure 6.1.  The results of treating the cells with the 
other inhibitors also showed similar patterns to the one described for PD158780 (Fig. 
6.7).  
91 
 
 
 
Figure 6.7:  The time-relationship between changes in energy dissipation factor and vinculin immunofluorescence 
staining within focal adhesions of MCF-10A-EGFR cells in response to 10 nM EGF.  The arrows indicate a few 
examples of focal adhesions.  The scale bar:  10 µm.   MCF-10A-EGFR cells were pretreated with the following 
inhibitors:  10 nM PD158780 (row A), 1 µM Cytochalasin D (row B), 10 µM L779450 (row C), 10 µM LY294002 
(row D), and 5 µM U73122 (row E).  Figures (AA), (BA), (CA), (DA), and (EA) show the quantitation of the areal 
densities of stained vinculin in relative fluorescence units (RFU) as a measure of focal adhesions (mean ± SEM; n = 
10).  A good correlation is shown between the normalized ∆D-response and the normalized RFU of focal adhesions.  
To confirm that the values of RFU and ∆D could be compared, each of the values used were normalized, i.e., was 
divided by the range covered.  For each quantity, the range was taken as the highest value (at 0 min) minus the lowest 
value (at 60 min).  All correlations are highly statistically significant (p < 0.005).  In each row (A) to (E), column (B) 
shows the fluorescence images of focal adhesions in a monolayer of cells prior to inhibition, labeled as uninhibited.  
Columns (C) to (G) show the fluorescence images of focal adhesions in a monolayer of cells after being exposed first to 
the inhibitor for 40 min, then to 10nM EGF for (C) 0 min, (D) 30 min, (E) 60 min, (F) 100 min, and (G) 150 min326.     
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To summarize, the levels of focal adhesions for each inhibitor are quantified and 
summarized as a function of time in a bar graph in Figures 6.7AA, 6.7BA, 6.7CA, 
6.7DA, and 6.7EA.  The values of the time-dependent changes in the level of focal 
adhesions and the corresponding ∆D-response curves were normalized as a way to ensure 
that both variables could be compared.  The Origin software and statistical package was 
used to examine the association between these two variables and to generate a p-value.  
The extremely low p-value for all five inhibitors (Table 6.1) indicates a strong association 
between the level of focal adhesions and the ∆D-response.  In other words, the 
restructuring of focal adhesions can be determined based on the time-dependent change 
in the ∆D-response. 
 
Table 6.1:  Calculated p-values for all five inhibitors used (10 samples used for each inhibitor studied). 
Inhibitor p-value 
PD158780 2.05 x 10-5 
Cytochalasin D 3.51 x 10-4 
L779450 4.41 x 10-4 
LY294002 4.12 x 10-3 
U73122 4.52 x 10-4 
 
6.3.3 Potencies of the inhibitors  
Up to this point we have been able to show that the QCM-D has the ability to 
measure the inhibitory effect of various inhibitors.  In order to obtain a more precise 
assessment of the effectiveness of the QCM-D, it is important to determine the IC50 
values for each one of the five inhibitors used.  We do this by comparing the 
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experimental values with the reported value, in this way we could assess the sensitivity 
and reliability of the QCM-D as a screening tool.   
 
Figure 6.8:  The amplitudes of the EGF-induced ∆D-responses at 40 min as a function of inhibitor concentrations.  The 
amplitudes are defined as the absolute value of the difference between the experimental value and the control value.  
The data, derived from the average of at least three different sets of independent data, were fit with the dose response 
function.  The resulting IC50 values are listed in Table 6.2 (A) PD158780.  IC50 = 64 ± 30 nM.  (B) Cytochalasin D.  
IC50 = 0.18 ± 0.11 µM.  (C) L779450.  IC50 = 1.0 ± 0.6 µM.  (D) LY294002.  IC50 = 1.1 ± 0.5 µM.  (E) U73122.  IC50 = 
2.5 ± 0.9 µM326. 
 
The IC50 value for each inhibitor was calculated based on its dose dependence 
determined by fitting the amplitudes of the ∆D-response values at 40 min as a function of 
the inhibitor concentration (Figure 6.8).  The values attained from the QCM-D 
measurements along with the values reported in the literature are listed in Table 6.2.  The 
reported IC50 value for Cytochalasin D was calculated based on its inhibitory effect on 
the mechanical properties of the cell sample
340
.  All the other values were calculated 
based on the in vivo inhibitory effects on the target enzymes in cell samples
335, 341-343
.  
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From the results obtained, it is clear that the experimental values agree well with the 
reported values (Table 6.2), which strongly supports the idea that the QCM-D has not 
only the sensitivity but also the reliability to be utilized as a sensing platform for drug 
screening.   
Table 6.2:  Comparison of IC50 values of the various inhibitors used
326. 
Inhibitor IC50 (QCM-D) IC50 (Literature) 
PD158780 64 ± 30 nM 52 nM341 
Cytochalasin D 0.18 ± 0.11 µM 0.25 µM340 
L779450 1.0 ± 0.6 µM 1 µM342 
LY294002 1.1 ± 0.5 µM 1.4 µM335 
U73122 2.5 ± 0.9 µM 1 – 2.1 µM343 
 
6.4 Conclusions 
In this study, we have used the QCM-D to track the EGF-induced response of 
MCF-10A-EGFR cells under different inhibitory conditions.  Based on the results 
obtained, we have been able to identify a complex cell de-adhesion process, which can be 
altered by inhibitors of the EGFR downstream signaling pathways and also by 
cytoskeleton formation in a dose-dependent manner.  To validate our findings, we 
determine the IC50 values of the dose dependencies of the inhibitors used.  The IC50 
values attained are in strong agreement with the values reported in the literature, thus 
demonstrating the sensitivity and reliability of the QCM-D as a screening tool.  We also 
used immunofluorescence staining as a way to confirm our findings.  With this method, 
we were able to verify the quantitative relationship between the ∆D-response and the 
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level of focal adhesions under such inhibitory conditions.  This data indicates that the 
restructuring of focal adhesions can be determined based on the time-dependent change 
in the ∆D-response.  Finally, this study has shown that the QCM-D has the potential to 
become a good sensing platform for screening drugs that target signaling and cytoskeletal 
proteins.   
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Chapter 7: EGCG-induced reactive oxygen species (ROS) formation in A431 cells  
7.1 Introduction 
Tea is one the most consumed beverages in the world.  Different studies have 
shown that green tea has the ability to protect against several types of cancers, such as 
skin, breast, lung and prostate
344
.  Most of the health benefits of green tea are attributed to 
its antioxidant properties
345-346
.  The main polyphenolic compounds found in green tea 
are the catechins
347-348
, which are depicted in Figure 7.1.  Out of all the catechins present 
in green tea, EGCG is the most abundant one, as it makes up 65% of the total catechin 
content and it is also the strongest antioxidant
349-351
. 
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Figure 7.1:  Structures of the major polyphenolic catechins found in green tea. 
 
Different studies have demonstrated that the EGCG-induced apoptosis is 
associated with oxidative stress imposed on tumor cells, especially by H2O2.  EGCG-
induced production of H2O2 has been shown under in vitro conditions
349
.  Studies have 
also shown that apoptosis induced by EGCG in certain in vitro models was reversed by 
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catalase, thus suggesting that H2O2 was the main cause of apoptotic pathway 
activation
352-353
.  Other studies have noted, that at low concentrations EGCG (<10 µM) 
behaves as a ROS scavenger, while at high concentrations it behaves as a ROS producer 
and can cause DNA damage (100 µM and above)
354
.  The different ROS levels found in 
the cell can influence the activity of signal transduction pathways leading to cell 
proliferation, apoptosis or necrosis, depending on the level of ROS present and also on 
cell type
355
.  Low doses of ROS tend to be mitogenic, while medium doses lead to 
temporary cell growth arrest, and high doses typically result in cell death either by 
apoptosis or necrosis
355
.  Although both of these events are seen as negative incidents for 
the cell, these processes can lead to the elimination of transformed cells (tumor 
suppression) and even in the down-regulation of immune responses
355
.  
During regular cellular activities, there are various processes inside the cells that 
generate ROS.  The most common ROS are H2O2, superoxide ion (O2
-
), and hydroxide 
radical (∙OH-), which are normal metabolic byproducts that are constantly generated by 
the mitochondria in growing cells.  The formation of ROS is a natural process of aerobic 
metabolism and is important for maintaining tissue oxygen homeostasis
356-357
.    
However, when these compounds are present at very high concentrations, they can 
damage cellular protein and lipids or DNA adducts that may help generate cancerous 
cells
358
.  Oxygen homeostasis is maintained through a natural series of reduction 
oxidation (redox) reactions
356
.  When oxygen homeostasis is not maintained, the cellular 
environment becomes oxidatively stressed.  It has been shown that 1-3% of oxygen used 
by the body is converted into ROS
359
.   In a physiological setting, the presence of 
antioxidants serves to prevent ROS concentrations from reaching really high levels 
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within the cells that can cause damage
353
.  Cells are equipped with enzymatic and 
nonenzymatic antioxidant systems to eliminate ROS and maintain redox homeostasis
360
.   
Examples of enzymatic antioxidants are catalase, glutathione peroxidase, superoxide 
dismutase and isoflavones, polyphenols, flavonoids, some vitamins and metals are a few 
examples of nonenzymatic antioxidants
361
. 
Despite the importance of ROS, especially H2O2, to cellular activities, the 
molecular mechanism of its production, accumulation, function, and degradation is not 
very well understood
362-363
.  Quantifying and tracking ROS is very difficult because most 
ROS are small and diffusible molecules
364
.  Although there are sensitive and selective 
methods for measuring of ROS outside the cells, testing for ROS inside the cells has 
proven to be a difficult task.  
Each type of ROS molecule has its own distinct reactivity in terms of selectivity 
and kinetics in a given biological setting
365
; this creates a need to develop methods that 
can detect specific ROS metabolites in living cells and organisms.  There are two types of 
methods for ROS detection, indirect and direct.  One of the most common direct methods 
for ROS detection is electro spin resonance (ESR)
366-367
.  The ESR spin-trapping method 
is a well-known, useful tool to detect short-lived radicals, such as ROS.  A five-
membered ring nitrone derivative, 5,5-dimethyl-1-pyrroline-N-oxide (DMPO), is widely 
considered to be the most useful spin-trapping reagent
368
.  The spin-trapping reagent 
reacts with short-lived radicals, which are eventually changed to long-lived radicals 
called spin-adducts.  Valuable information can be obtained from the ESR spectra of spin-
adducts, it includes the g-value, hyperfine coupling constant (hfcc) and spin 
concentration
369
.  The g-value is determined from the resonance magnetic field and the 
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resonance frequency observed as ESR signals.  The hccc represents the splitting of an 
ESR spectrum, and is determined by analyzing the splitting of the spectrum of spin 
adducts
369-370
.  The concentration of a free radical is determined as double integrals of the 
ESR spectrum of a spin adduct
371-373
.  Major weaknesses of ESR are that the 
spectrometers are very expensive and they occupy a large amount of space
373
.  Tabletop 
spectrometers are available, which are less expensive and relatively smaller in size.  They 
are not as sensitive or versatile as the larger floor models.  Another weakness of this 
method is that it is important to have extensive training to operate the spectrometers 
correctly
373
.  The most traditional indirect methods include chemiluminescence
363, 374-375
, 
fluorescence 
376-378
 and flow cytometry
379-380
.  The chemiluminescence assay measures 
the oxidative end product produced by an in-vitro reaction between ROS and a reagent
381-
382
.  The reaction causes light to be emitted, which is measured with a luminometer
382
.    
Similarly, flow cytometry can be used for the detection of ROS.  The main advantage of 
flow cytometry is that it measures fluorescence per cell.  The cells are excited by the light 
source and light emitted from the cells is converted to electrical pulses by optical 
detectors
383-384
.  Finally, fluorescence methods can also be assessed using simple 
microscopy, which is an inexpensive procedure
376, 378, 385
.  However, a relatively small 
number of cells are assessed in each sample.  One of the main disadvantages of indirect 
methods is that most of the assays require tagging of the cellular molecules with 
fluorescent dyes, thus creating a non-native and physiologically irrelevant cellular 
environment for the molecules of interest, which might lead to invalid results
373
.   
These problems can be avoided with the use of real-time and label free-sensor 
technologies.  The use of devices that use biomolecules as analytical tools could provide 
101 
 
 
a better advantage compared to traditional methods, this is due to their simplicity, 
selectivity and quick response in real-time.    Biosensors are often described as analytical 
tools that are based on two main components, a biological recognition compound and a 
physical transducer (sensor).  Sensors can also be described as direct and indirect
386
.  
Direct sensors are those that follow in real-time the binding event while indirect sensors 
are those that only measure the result of a binding event.  Since direct sensors do not 
require labelled species for detection of the analytes, the detection permits label-free and 
real-time analysis
386
.  The two most common methods that can be used for this type of 
oxidative stress detection are electrochemical impedance spectroscopy (EIS) 
387-388
 and 
surface plasmon resonance (SPR)
389-390
.       
This study describes a novel application of QCM-D, a real-time and label free 
sensor technology, for the detection of EGCG-induced ROS formation.  The main focus 
of this study was to use the QCM-D to track in real-time the EGCG-induced ROS 
formation in human epidermoid carcinoma A431 cells.  This study shows that EGCG-
induced ∆D-response can be correlated to the EGCG-induced ROS formation.  The 
results from this study give us a quantitative tool to investigate the EGCG-induced ROS 
formation in real-time using a label-free technique.  To our knowledge, none of these 
techniques have been applied to the detection of EGCG-induced ROS formation.     
7.2 Methods  
7.2.1 EGCG-Peracetate Synthesis391  
 EGCG (36.6 mg, 0.079 mmol) was dissolved in a mixture of pyridine (0.8 mL, 
9.9 mmol) and acetic anhydride (0.8 mL, 8.5 mmol). The reaction vessel was sealed, 
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flushed with nitrogen and stirred at 40 °C for 24 h. 5 mL ice cold DI water was added to 
the reaction mixture and was allowed to stir in an ice bath for 20 min forming an off 
white precipitate. The water was removed and crude product was redissolved in ethyl 
acetate and purified using preparative thin layer chromatography. A mixture of 
hexanes/ethyl acetate (1:2) was used to develop the silica plates. The area of silica 
containing the product (Rf = 0.4) was scraped off using a spatula and the product was 
washed off with ethyl acetate. The solvent was removed, leaving 43 mg EGCG-
peracetate (68 % yield).  The mass spectrum confirms the presence of the product, CI-MS 
m/z: 795.175 [M+1]. 
7.2.2 Measurement of intracellular ROS levels392 
 The ROS levels assay measures the accumulation of intracellular ROS levels.  
The non-fluorescent dye DFDA passively diffuses into the cells, where the acetate groups 
are cleaved off by intracellular esterases.  The metabolites are trapped within the cells 
and oxidized by ROS, mainly H2O2, to the fluorescent form, 2’,7’-dichlorofluorescein, 
which was measured using a fluorimeter, model PE LS55B, from Perkin Elmer.  Cells 
(1.8 x 10
6
 cell/mL) were incubated with assay buffer (20 mM HEPES in HBSS buffer, 
pH 7.2) at 37 
o
C for 1 h, they were then incubated with 10 µM DFDA in a 12-well plate 
for 1 h at 37 
o
C.  After incubation cells were washed three times with assay buffer and 
incubated with 100 µM EGCG for the indicated time periods.  All incubations were 
performed in the dark.  The cells were lysed using a lysis buffer (10 mm Tris-HCl pH 7.4, 
10 mm EDTA and 0.5 % SDS) and the intracellular ROS levels were measured using a 
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fluorimeter, at an excitation wavelength of 495 nm and an emission wavelength of 529 
nm.  The software used was FL Winlab v.4.00.02.      
7.3     Results  
 In this study, we used the QCM-D as a sensing platform to study the effect of 
EGCG and the detection of EGCG-induced ROS formation on A431 cells.  This cell line 
was chosen in this study because it is a cancerous cell line and we wanted to determine 
the effect that EGCG-induced ROS formation has on cancer cells. Because of EGCG’s 
poor bioavailability, the synthesis of a pro-drug form of EGCG was prepared to improve 
its bioavailability.  Here we prepared the peracetate form of EGCG, which has been 
found to be more stable than EGCG
393-394
.  We evaluated the dose response of the EGCG- 
and the EGCG-Peracetate-induced cell de-adhesion process in A431 cells using the 
QCM-D.  Since we wanted to correlate these results to the H2O2 formation, we treated the 
A431 cells with various doses of H2O2 and we examined the dose response of the H2O2-
induced cell de-adhesion process.  The similarities that we found among both 
experiments led us to measure the formation of intracellular ROS after treating the A431 
cells with EGCG.   We also verified the time dependence of EGCG using 
immunofluorescence imaging.  All QCM-D experiments were conducted at 37 
o
C, and 
stable baselines were achieved before EGCG and EGCG-peracetate were added.  For 
each compound, we picked six different concentrations, which cover the range that 
permits the attainment of a dose-response curve.  We tried to minimize the possible 
variations that can occur during cell-based assays and fluorescence experiments, by using 
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cells from at least three different cultures. Additionally, control experiments were 
designed and performed under individual conditions.   
7.3.1 QCM-D measurements 
 The effect of both EGCG and EGCG-Peracetate on A431 cells was studied by 
treating the cells with 7 different doses of EGCG and EGCG-Peracetate (0, 20, 50, 100, 
150, 200, 300 µM).  Both compounds were added to confluent monolayers of both cell 
lines on QCM-D crystals and a dose response curve was generated for each cell line 
(Figure 7.2).    
 
Figure 7.2:  Real time quartz microbalance with dissipation monitoring (QCM-D) measurements (overtone n = 3) of 
the ∆D-response of A431 cells to EGCG and EGCG-peracetate at 37 oC.  (A)  The ∆D-response of the cells was 
increased by EGCG at various doses (0, 20, 50, 100, 150, 200, 300 µM).   Note that for most of the ∆D-responses, the 
large peak in the curve is well separated in time from the small positive value of ∆D at 10 min due to the mechanical 
perturbation of the layer of cells when the solution was added.  However, for the 300 μM dose, the small ∆D due to the 
perturbation underlay the large peak.  Thus, the ∆D–value for this large peak was corrected by subtracting an amount 
due to mechanical perturbation.   (B)  The ∆D-response of the cells was suppressed by EGCG-peracetate at various 
doses (0, 20, 50, 100, 150, 200, 300 µM).    
     
 
 Figure 7.2A shows the results of a dose-response of the EGCG induced cellular 
response measured with the QCM-D.  In this experiment, 7 different doses (0, 20, 50, 
100, 150, 200 and 300 µM) of EGCG were introduced into confluent monolayers of 
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A431 cells on QCM-D sensor crystals.  After a baseline was achieved, which usually 
takes ~60 min at 37 
o
C; each assay solution was replaced with the different EGCG 
concentrations.  The ∆D-responses at the order of overtone, n = 3, were recorded at 37 oC 
for 3 h.  Although the QCM-D is able to record simultaneous measurements of both ∆D- 
and ∆f-responses, we focused on the ∆D-responses because it is a more sensitive 
indicator of the cellular responses than the ∆f-response266.   The Δf-responses were also 
recorded but, unlike the ΔD-responses, showed no measurable response and no sensitivity 
to dose.     
In Figure 7.2A, the ∆D-response curve labeled 0 µM EGCG represents the 
control.  It corresponds to A431 cells responding to only assay buffer without the 
presence of EGCG.  Once EGCG is added at the aforementioned doses, the ∆D-response 
curve exhibits an immediate rise upwards, which is due to the mechanical perturbation 
caused by adding a liquid to the cell layer.  This upward rise of the ∆D-response is more 
noticeable at the lower doses (0, 20, 50, 100 µM) than at the higher doses used (150, 200, 
300 µM).  After the initial peak, the ∆D-response of the 20 µMm EGCG levels off, thus 
portraying a similar profile to that of the control, with the main difference being that the 
curve is only a few dissipation units higher than that of the control.  The ∆D-response of 
the 50 µM EGCG starts to show a moderate increase that lasts for ~80 min, until it 
reaches a maximum peak value at 130 min, before it monotonically decreases.      
  The overall trend observed when treating the cells with EGCG is that there is a 
peak formed by the maximum value of the ∆D-response.  This peak shifts to shorter times 
as the concentration of EGCG increases from 100 µM to 300 µM, as seen in Figure 7.2A.  
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All of the peaks vary in intensity.  A plot of the peak value of the EGCG-induced, ∆D-
response (Figure 7.3) versus the EGCG concentration used shows a linear relationship 
from EGCG concentrations of 0 µM to 150 µM EGCG doses; from concentrations of 150 
µM to 300 µM, the peak value of ∆D shows negligible change.  This plot suggests that 
the highest dose of EGCG needed for a maximum response is 150 µM.   
 
Figure 7.3:  Amplitude of the EGCG-induced ∆D-response as a function of EGCG concentration (µM).  The ∆D-
response corresponds to the maximum peak values obtained when various doses of EGCG were used (   0,    20,    50,    
100,    150,    200,       300 µM).  In order to separate mechanical perturbation from peak for 300 µM EGCG, the ∆D -
value that corresponds to the peak caused due to mechanical perturbation in the 0 µM EGCG curve, was subtracted 
from that of the 300 µM  ∆D- value.       
 
   
Even though, EGCG has been shown to possess several health benefits, it has one 
limitation, which is its poor bioavailability.  EGCG has several hydrogen bond donors 
(i.e., hydroxyl groups), it also has a large polar molecule surface area, and it is considered 
to be poorly absorbed by “Lipinski’s Rule of 5”395-396.  Another factor to consider is that 
EGCG undergoes in vivo metabolic transformation into various metabolites
394
.  The 
synthesis of a prodrug form of EGCG could improve its bioavailability.  We prepared the 
peracetate form of EGCG, which has been found to be more stable than EGCG by other 
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groups
393-394
.  This improvement is achieved by blocking the polar side chains, thus 
increasing the hydrophobicity of the molecule
397
.  Landis-Piwowar et al.  found that by 
introducing peracetate-protecting groups to the reactive hydroxyls of EGCG, the prodrug, 
EGCG-peracetate was better absorbed into the cells; they also discovered that EGCG-
peracetate was converted to the parent EGCG under cell-free conditions and the 
converted EGCG was accumulated in greater quantity than natural EGCG
398
.   
Acetylation of EGCG improved the cell uptake and growth inhibitory activity of 
EGCG against two types of cell lines, human esophageal squamous cell carcinoma 
(KYSEE150) and human colon adenocarcinoma cells (HCT116)
399
.  The EGCG-
peracetate can increase the intracellular concentrations, as a result of increased cell 
uptake over a short term of 1 hr, but once the EGCG-peraceate is converted back to 
EGCG, it goes through biotransformation and efflux at a rate similar to EGCG over a 
long term of 24 hr
399
.   
Figure 7.2B shows the effect of EGCG-peracetate on the ∆D-response of A431 
cells.     Due to its hydrophobicity, EGCG-peracetate could potentially get inside the cells 
much faster than EGCG and once inside, it could turn back into its parent form
398
.  When 
the cells were treated with EGCG-peracetate, the ∆D-response was very different to the 
EGCG-induced ∆D-response, suggesting that exposure to EGCG-peracetate was causing 
the cells to de-adhere from the surface.  At lower doses (20, 50, 100 µM) the cell de-
adhesion observed from the ∆D-response took a longer time than the corresponding 
processes obtained from the higher doses (150, 200, 30 µM).  In fact, the ∆D-response 
profiles for the lower doses follow a similar pattern: after the addition of the solution, 
there is a rapid decline of the ∆D-response that lasts for about ~25 min, after this time, 
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the ∆D-response starts to increase, thus indicating that the cells are adhering more 
strongly to the surface, this takes ~125 min.  It is after this time, that the ∆D-response 
starts to decrease (~30 min) again, which corresponds to cell de-adhesion.  The ∆D-
response profiles of the higher doses of EGCG-peracetate are different.  Once the 
solution has been added, there is still a rapid decline of the ∆D-response, which lasts for 
about ~25 min.  At this point, the ∆D-response starts to increase for about ~50 min. This 
behavior can be attributed to the cells adhering more strongly to the surface. Thereafter 
there is a fast decline in a dose-manner of each one of the ∆D-responses, which 
corresponds to cell de-adhesion.        
7.3.2  Susceptibility of A431 cells to H2O2 
 In order to confirm the EGCG- and EGCG-peracetate-induced ∆D-response on 
A431, we treated the A431 cells with various doses of H2O2 (0, 0.05, 0.1, 0.5, 1, 2 mM).  
By treating the cells with H2O2, we were trying to find a correlation between the EGCG- 
and EGCG-peracetate-induced ∆D-responses and H2O2 formation. 
Figure 7.4 shows the ∆D-response of A431 cells to exogenous H2O2 at various 
concentrations.  The ∆D-response did not seem to be affected when lower doses of H2O2 
were used (0.05 and 0.1 mM).  However, when the concentration of H2O2 was increased 
to 0.5 mM, the ∆D-response decreased following initial increase.  The ∆D-response 
observed at the higher doses (0.5-2 mM) resembled that of the EGCG-peracetate-induced 
∆D-response.  A prominent peak appears around 50 min of treating the cells with H2O2.  
This peak does not level off when 0.5 and 1 mM concentrations are used, but instead it 
decreases significantly.  We speculate that the peak observed at 30-60 min could be 
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similar to the peaks in Figure 7.2A produced by EGCG, which can produce reactive 
oxygen species (ROS).   In the case of EGCG, the peaks were linked (by fluorescence 
studies) to an increase in focal adhesions, and therefore in cell adhesion followed by a 
decrease in focal adhesions, and in cell adhesion.   In neither case do we have an 
explanation for what is occurring at the molecular level.   
       
Figure 7.4:  Real-time quartz crystal microbalance with dissipation monitoring (QCM-D) measurements (overtone of n 
= 3) of the ∆D-responses of A431 cells to H2O2 at 37 
oC.  The ∆D-responses of the cells are suppressed when lower 
doses of H2O2 are used (0.05 and 0.1 mM), but the ∆D-responses are enhanced when higher doses of H2O2 are used 
(0.5, 1, and 2 mM). 
 
These results show a strong relationship between the EGCG-induced ∆D-response 
and the H2O2-inducced ∆D-response on A431 cells.  At low concentrations of H2O2, the 
∆D-response resembles that of EGCG, but at higher doses of H2O2, the ∆D-response is 
similar to that of EGCG-peracetate.  The resemblances observed could be accredited to 
the fact that both of these compounds, H2O2 and EGCG-peracetate, can enter the cell 
membrane more freely compared to EGCG.  For example, H2O2 has been shown to enter 
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the cell through a water channel known as Aquaporin-3 (AQP3)
400-401
, which facilitates 
the uptake of H2O2 into mammalian cells
400-401
.  It has been shown that when EGCG-
peracetate enters the cell, it was converted back to EGCG and the converted EGCG is 
accumulated in greater quantity than natural EGCG
398
.  These findings suggest that 
higher intracellular concentrations of EGCG induce production of higher concentrations 
of H2O2.            
7.3.3 Generation of Intracellular ROS Levels 
 To further confirm our previous findings, we determined the EGCG-induced ROS 
levels for both A431 cells.  The working concentration that was chosen for this 
experiment was 100 µM EGCG.  This concentration was picked based on the EGCG 
dose-dependent study shown in Figure 7.2.   
This experiment was set up with identical conditions to the QCM-D experiments; 
this was done as a way to keep consistency among the results.  A431 cells (1.8 x 10
6
 
cells/mL) were seeded on glass cover slips using the methods described in chapter 4.  The 
controls were set up as follows, the cells were incubated with assay buffer (20 mM 
HEPES in HBSS buffer) for 1 h at 37 
o
C and then they were exposed to 10 µM DFDA for 
1 h at 37 
o
C.  After incubation, the cells were lysed using a lysing buffer (section 7.2.2) 
and measurements were taken using a fluorimeter, model PE LS55B.  Final data resulted 
from subtraction of the control. 
 
111 
 
 
 
Figure 7.5:  Time relationship between changes in energy dissipation factor, ∆D, (blue) and ROS intracellular levels 
(red) in response to EGCG is shown in this Figure (mean ± std. dev.; n = 10.).  A431 cells were treated with 100 µM 
EGCG at the indicated times (0, 15, 30, 45, 60, 120, 180 min).  Cells were lysed and measurements were taken using a 
fluorimeter at an excitation wavelength of 495 nm and an emission wavelength of 529 nm. 
 
    
 
Figure 7.6:  Relationship between normalized ∆D values and normalized ROS intracellular levels in response to EGCG 
is shown in this Figure.  A correlation coefficient of r = 0.95 was attained.  
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Figure 7.5 shows the ROS levels induced by EGCG (red dots) in A431 cells 
immediately after addition of 100 µM EGCG.  The measurement of intracellular ROS 
levels was carried out by EGCG-induced ROS levels increased in a time-dependent 
manner, reaching a maximum at 60 min, and decreases dramatically thereafter (120-180  
min).  The normalized EGCG-induced ROS levels appeared to match the normalized 
EGCG-induced ∆D-response (blue line).  This good match between ROS levels and the 
∆D-response suggests a strong association between these two quantities.  In order to 
further verify these findings, a plot of discrete, normalized ∆D-values versus normalized 
intracellular ROS values was created (Figure 7.6).  The correlation coefficient for these 
two normalized variables is r = 0.95, verifying a strong association.  In practical terms, 
we can follow the EGCG-induced H2O2 production with the dissipation factor of the 
QCM. 
In order to understand more about the intracellular ROS levels, we studied the 
relationship between magnesium (Mg
2+
) and oxidative stress.  Various studies have 
shown direct evidence that the depletion of Mg
2+
 affected the levels of intracellular 
ROS
402-404
.  Yang et al. suggested that a deficiency in Mg
2+
 can induce the increase of 
H2O2 production, and it can also decrease catalase activity in chick embryos, thus causing 
oxidative stress as well as cell peroxidative damage
403
.  Figure 7.7 shows what happens 
when A431 cells were treated with EGCG in regular assay buffer versus other buffers 
that are lacking either calcium and/or magnesium ions. 
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Figure 7.7:  Real-time quartz crystal microbalance with dissipation monitoring (QCM-D) measurements (overtone n = 
3) of the ∆D-responses of A431 cells to 100 µM EGCG at 37 oC.  EGCG was prepared in various buffers (20 mM 
HEPES in HBSS, Ca2+ and Mg2+ free buffer, Ca2+ free buffer and Mg2+ free buffer). 
 
 
The black curve represents the control; the EGCG used was prepared using the 
assay buffer that is used throughout this experiment.  This buffer was prepared with 20 
mM HEPES in HBSS.  The red curve shows the ∆D-response of 100 µM EGCG prepared 
in a Ca
2+
 free buffer.  It is important to note that in a Ca
2+
 free buffer the ∆D-response is 
similar in intensity to that of the control; the only difference is that the peak observed in 
the control, appeared at an earlier time (~45 min).  When EGCG is prepared using an 
Mg
2+
 free buffer (green line), the ∆D-response is different to that of the control.  
Although it follows a similar trend to the control, it appears at a much earlier time (~35 
min).  The last buffer used to prepare a 100 µM EGCG solution was the Ca2+ and Mg2+ 
free buffer (blue line).  The ∆D-response for this experiment did follow a similar pattern 
to that of the control, but instead the ∆D-response increased at approximately the same 
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time as the Ca
2+
 free buffer did (~45 min) and it leveled off after that.  The formation of a 
peak was never observed when this buffer was used.  From the results we concluded that 
the QCM-D could be used to assess the cellular concentration of Mg
2+
 and its effect on 
cell adhesion.    
7.3.4 Fluorescence Imaging 
The use of label free technologies allows us to record real-time, measurable 
signals by taking time-dependent cellular responses, which are usually the result of 
several changes that relate to cell morphology, adhesion, ion distribution and mass 
distribution 
183-184
.  Since these results are consequences of various factors within the 
cells, it is hard to identify the particular cellular process responsible for the effect. 
 In our earlier work, we studied the time-dependent cell de-adhesion in response to 
EGF with fluorescence imaging.  We were able to establish a quantitative relationship 
between the ∆D-response obtained from the QCM-D and the level of focal adhesions, 
which was quantified by measuring the areal density of immunostained vinculin 
270, 301, 
326
.  Following the same approach, we verified the effect of EGCG on A431 cells and 
further established the connection between the ∆D-response and the restructuring of focal 
adhesions.   
We examined the time-dependent effect of EGCG by studying the changes in 
areal density of focal adhesions (Figure 7.8).  Figure 7.8B-F shows fluorescence images 
of immunostained vinculin withtin focal adhesions of  A431 cells that had been treated 
with 100µM of EGCG for various times (0, 30, 60,120, 180 min).  Before the cells were 
exposed to EGCG (0 min), there are several focal adhesions observed as short bright 
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streaks of vinculin (Figure 7.8B).  Once the cells were exposed to 100 µM of EGCG for 
30 min, the cells exhibit a few more spots of stained vinculin (Figure 7.8C), indicating an 
increase of focal adhesions.  Exposing the cells to EGCG for 60 min showed a sharp 
increase in fluorescence as shown in Figure 7.8D. However, a much longer exposure to 
EGCG, 120 and 180 min (Figures 7.8E-7.8D), causes further reduction of stained 
vinculin compared to the 60 min exposure.   
 
 
Figure 7.8: Time-dependent relationship between changes in energy dissipation factor and vinculin 
immunofluorescence staining within focal adhesions of A431 cells in response to EGCG.  Examples of focal adhesions 
are indicated with arrows.  Scale bar:  10 µm.  The cells were treated with each EGCG.  (A)  Quantitiation of the areal 
densities of stained vinculin in relative fluorescence units (RFU) as a measure of focal adhesions (mean ± SEM; n = 
10).  A relationship is shown between the normalized ∆D-response and the normalized RFU of focal adhesions.  To 
verify that the values of RFU and ∆D could be compared, each one of the values was normalized, i.e., was divided by 
the range covered.  For each quantity, the range was taken as the highest value (at 60 min) minus the lowest value (at 0 
min).  Figures (B) to (F) show the fluorescence images of focal adhesions in a monolayer of cells after being exposed to 
100µM EGCG for (B) 0 min, (C) 30 min, (D) 60 min, (E) 120 min, and (F) 180 min. 
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Overall, when exposed to 100 µM EGCG, A431 cells underwent a time-
dependent restructuring of focal adhesions, which corresponded to adhesion.  Cells 
became more strongly adhered to the surface (~30 min), and then slight de-adhesion.  
This pattern is consistent with the one observed in the QCM-D measurements in Figure 
7.8A.  These results show a relationship of cell adhesion and the ∆D-response.  This 
suggests that the observed change in ∆D-response correlates with the change in cell 
adhesion, which also relates to the change in H2O2, suggesting that H2O2 might induce 
the change in cell adhesion.   
 To further verify the ability of the QCM-D to measure the change in H2O2, we use 
a different cell line, MCF-10A.  The same experiments that we performed on the A431 
cells were implemented on  MCF-10A cells.     
 
Figure 7.9:  Real time quartz microbalance with dissipation monitoring (QCM-D) measurements (at the order of 
overtone n = 3) of the ∆D-response of MCF-10A cells to EGCG and EGCG-peracetate at 37 oC.  (A)  The ∆D-response 
of the cells was increased by EGCG at various doses (0, 20, 50, 100, 150, 200, 300 µM).  (B)  The ∆D-response of the 
cells was suppressed by EGCG-peracetate at various doses (0, 20, 50, 100, 150, 200, 300 µM). 
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The EGCG-induced ∆D-response of the MCF-10A cells portrays a similar trend 
to that of A431 cells (Figure 7.9A).  For the lower doses (20 and 50 µM) there was no 
peak observed after addition of EGCG.  However, the appearance of a smaller peak was 
noted in the 100 µM EGCG curve, the intensity of this peak was considerable smaller 
compared to that obtained from the A431 experiment (Figure 7.2).  For the higher doses 
(150, 200, 300 µM), the peaks appeared immediately after exposing the cells to EGCG, 
and the intensity of each peak increased with increasing concentration.   Once again, the 
intensity of these peaks was substantially smaller when compared to those from the A431 
experiment (Figure 7.2).         
Figure 7.9B shows the EGCG-peracetate-induced ∆D-response on the MCF-10A 
cells.  When MCF-10A cells were treated with EGCG-peracetate, the ∆D-response for 
the lower doses (20, 50 µM) appeared units below the control, suggesting that the 
compound was causing the cells to slightly de-adhere from the surface.  This behavior 
was different from that of the A431 cells, where the ∆D-response for the lower doses 
appeared a few units higher than the control.  When the higher concentrations (150, 200, 
300 µM) of the EGCG-peracetate were used, the ∆D-response was very similar to the 
ones observed when EGCG-peracetate was used on A431 cells.  Proposing that at lower 
doses the compound causes a slight de-adhesion from the quartz crystal, but at higher 
doses, the compound considerably decreases the ∆D-response after ~40 min of treatment.   
Treating the A431 and MCF-10A cells with EGCG yielded some similarities in 
their ∆D-responses.  At lower doses of EGCG, the cells appeared to adhere slightly 
stronger to the crystal surface; both ∆D-responses attained were above the control curve.  
At higher concentrations of EGCG prominent peaks were observed.  The main difference 
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observed between the ∆D-responses of the A431 and MCF-10A cells is that the 
appearance of the peak came earlier and exhibited a higher intensity with increasing 
concentration of the compound, whereas the treatment of MCF-10A cells with EGCG 
produced a peak at nearly the same time, but its intensity increased with increasing 
concentration.   On the other hand, when both cell lines were treated with EGCG-
peracetate, the ∆D-responses for both cells lines were similar.  At lower doses there is a 
slight de-adhesion observed, while at higher doses, the EGCG-peracetate-induced ∆D-
response and cell de-adhesion is observed.  This could be due to the fact that EGCG-
peracetate is more hydrophobic, thus being able to get inside the cell more freely.  The 
results from this section could tie to the EGCG-induced production of ROS 
405-407
.    
The next experiment that we ran was to determine the susceptibility of the MCF-
10A cells to H2O2, Figure 7.10.      
 
Figure 7.10:  Real-time quartz crystal microbalance with dissipation monitoring (QCM-D) measurements (overtone n = 
3) of the ∆D-responses of MCF-10A cells to H2O2 at 37 
oC.  The ∆D-responses of the cells were enhanced with H2O2, 
at various doses (0, 0.05, 0.1, 0.2, 0.5, 1, 2 mM). 
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The susceptibility of MCF-10A cells to exogenous H2O2 is not very different to 
that observed with A431 cells, Figure 7.4.  Similarly to A431 cells, the ∆D-response was 
similar to that of the control when the cells were exposed to lower doses of H2O2. 
However, when higher concentrations of H2O2 were used (0.5–2 mM) the ∆D-response 
decreased.  The main difference observed between both cells lines is the absence of the 
peak that appeared around 25 min when the A431 cells were treated with H2O2.  The 
absence of this peak can be correlated to the EGCG-induced ∆D-response of  MCF-10A, 
Figure 7.9A. 
Next, we examined the EGCG-induced ROS levels for MCF-10A cells. A similar 
behavior was observed when the ROS level generated by EGCG (blue dots) in MCF-10A 
cells (purple line) were plotted against the 100 µM EGCG-induced ∆D-response (Figure 
7.11).   
 
Figure 7.11:  Time relationship between changes in energy dissipation factor (purple) and ROS intracellular levels 
(blue) in response to EGCG is shown in this Figure (mean ± std. dev.; n= 10.).  MCF-10A cells were treated with 100 
µM EGCG at the indicated times (0, 15, 30, 45, 60, 90, 120, 180 min).  Cells were lysed and measurements were taken 
using a fluorimeter at an excitation wavelength of 495 nm and an emission wavelength of 529 nm. 
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 In Figure 7.11, we observed that the EGCG-induced ROS levels increased in a 
time-dependent manner, where a maximum is reached at 15 min, and after this time, the 
ROS levels decreased dramatically at about 45 min and remain steady for about 40 min 
and then it slowly decreases for the remaining of the experiment. These results show once 
again that the QCM-D can be used as tool to track the EGCG-induced ∆D-response and 
H2O2 production in a quantitative way.   
 The last step was to verify our results using fluorescence imaging to study the 
time-dependent effect of EGCG by probing the changes in areal density of focal 
adhesions of MCF-10A cells (Figure 7.12).  Figure 7.12B-F shows fluorescence images 
of immunostained vinculin within focal adhesions of   MCF-10A cells that were treated 
with 100 µM of EGCG at various times (0, 15, 30, 45, 60 min).  The control (0 min) 
shows focal adhesions observed as short bright streaks of vinculin (Figure 7.12B).  Once 
the cells were exposed to 100 µM of EGCG for 15 min, the cells exhibited more spots of 
stained vinculin (Figure 7.12C), indicating an increase in focal adhesions.  A 30 min 
exposure to EGCG also caused an increase in the spots of stained vinculin, compared to 0 
min exposure to EGCG, as shown in Figure 7.12D.  When the cells were exposed to 
EGCG for a longer period of time (45-60 min), there was a slight reduction of stained 
vinculin compared to the 15 min exposure.    Just as with the A431 cells, the MCF-10A 
cells, when exposed to 100 µM EGCG, underwent time-dependent restructuring of focal 
adhesions, which correspond to adhesion, cells becoming more strongly adhered to the 
surface (15 min), and slight de-adhesion (45 min).  This pattern is consistent with the one 
observed with the QCM-D measurements in Figure 7.12A. 
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Figure 7.12:  Time-dependent relationship between changes in energy dissipation factor and vinculin 
immunofluorescence staining within focal adhesions of MCF-10A cells in response to EGCG.  Examples of focal 
adhesions are indicated with arrows.  Scale bar:  10µm.  The cells were treated with each EGCG.  (A)  Quantitiation of 
the areal densities of stained vinculin in relative fluorescence units (RFU) as a measure of focal adhesions (mean ± 
SEM; n = 10).  A relationship is shown between the normalized ∆D-response and the normalized RFU of focal 
adhesions.  To verify that the values of RFU and ∆D could be compared, each one of the values was normalized, i.e., 
was divided by the range covered.  For each quantity, the range was taken as the highest value (at 15 min) minus the 
lowest value (at 0 min).  Figures (B) to (F) show the fluorescence images of focal adhesions in a monolayer of cells 
after being exposed to 100 µM EGCG for (B) 0 min, (C) 15 min, (D) 30 min, (E) 45 min, and (F) 60 min. 
 
     
The similarity between both cell lines is that when exposed to 100µM EGCG, 
there is an increase in cell adhesion.  For MCF-10A cells this process occurs faster (~15 
min) than for A431cells (~60 min).  Based on the results obtained from both cell lines, 
there is clear relationship between cell adhesion and the QCM-D response.  It suggests 
that the observed change in EGCG-induced ∆D-response correlates with the change in 
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cell adhesion, which also correlates with the H2O2-induced ∆D-response.   Thus, 
indicating that H2O2 might induce the change in cell adhesion.  These observations 
support our theory on the principle of the QCM-D, that is, the ∆D-response measures the 
change in cell adhesion
270, 301, 326
. 
7.3.5 Inhibitory effect of EGCG on EGFR 
EGCG has been shown to inhibit the growth of several types of cancer cell 
lines
408-411
.  This is associated with inhibition of phosphorylation (i.e., activation) of the 
EGFR and inhibition of several downstream signaling pathways
344, 408-409
.  Studies have 
shown that this inhibition can lead to growth cessation and cell apoptosis
412
. Therefore, in 
this study, we examined the inhibitory effect of EGCG on EGFR in A431 cells using the 
QCM-D.   
 To determine whether EGCG inhibits EGFR function, four different doses of 
EGCG (0, 50, 70 and 100 µM), were introduced into confluent monolayers of A431 cells 
on QCM-D sensor crystals.  Each solution was incubated at 37 
o
C for 40 min; after this 
time, each solution was replaced with 10 nM EGF solution.  The ∆D-responses at the 
order of overtone, n = 3, were recorded at 37 
o
C for 3 h.    Just as in our previous studies, 
we only focus on the ∆D-responses because it is a more sensitive measure of the EGF-
induced cellular responses than the ∆f-responses270.   
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Figure 7.13: Real-time QCM-D measurements (overtone n = 3) of the ∆D-responses of A431 cells to 10 nM EGF at 
37oC. 
 
  
Figure 7.13 shows the results of a dose-response inhibition of the EGF-induced 
cellular response measured with the QCM-D.  The ∆D-response curve that is labeled 0 
µM represents the time-dependent profile of A431 cells responding to 10 nM EGF 
without the presence of EGCG.  After the addition of EGF, this ∆D-response curve shows 
a sharp upward spike, which is the result of the mechanical perturbation caused by adding 
a liquid to the cell layer.  After this initial spike, the ∆D-response curve stays constant for 
the next 80 min.  At around 100 min, there is a slow increase in the ∆D-response, which 
appears to be the formation of a peak.  Similar to the ones observed in the EGCG-induced 
∆D-response (Figure 7.2), but the peak observed is of less intensity.   
In the presence of EGCG, the formation of these peaks in each of the EGF-
induced ∆D-response curve was significantly reduced compared to results in Figure 7.2.  
All of these observable changes to the EGF-induced ∆D-response suggest that that EGCG 
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could block cellular binding of EGF by binding to its EGFR, thus preventing its 
autophosphorylation and downstream signal transductions.  Work by Liang et al. showed 
that EGCG blocked EGF binding to EGFR, thus suggesting that the inhibition of 
proliferation and suppression of the EGF signaling by EGCG might mediate dose-
dependent blocking of ligand binding to its receptor, and subsequently through inhibition 
of EGF-R kinase activity
412
.     
In the next experiment, the effect of EGCG on A431 cells was tested for a longer 
period of time (~18 h).  The cells were exposed to four different concentrations of EGCG 
(0, 50, 70, 100 µM) overnight.  Each EGCG solution was added to the growth medium 
containing no EGF and introduced into confluent monolayers of A431 cells on QCM-D 
sensors.  After the 18 h incubation with EGCG, the cells were washed and each solution 
was replaced by 10 nM EGF. For this particular study, 10 nM EGF was used for the 
QCM-D measurements.  This dose of EGF was chosen based on the dose response 
studies done by Chen et al. as that the ∆D-response plateaus when the cells are treated 
with 10 nM EGF
266
.    
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Figure 7.14:  Real-time quartz crystal microbalance with dissipation monitoring (QCM-D) measurements (overtone n = 
3) of the ∆D-responses of A431 cells to 10 nM epidermal growth factor receptor (EGF) at 37 oC.  The ∆D-responses of 
the cells were suppressed with EGCG at various doses (0, 50, 70, 100 µM).  A431 cells were pretreated overnight (~18 
h) with EGCG. 
 
   
Figure 7.14 shows the ∆D-responses of A431 cell to an overnight exposure of 
EGCG .  Based on the results, there is a clear dose dose-dependence response.  The ∆D-
response for the control, which was only treated with 10 nM EGF displays a similar 
profile for this inhibitor 
266
.  The sharp upward spike observed is again due to mechanical 
perturbation to the cells when a new solution is added to the experiment.  After the initial 
peak, the ∆D-response curve shows a rapid decline that continues for about ~20 min,   
which could be assigned to rapid cell de-adhesion.  At 30 min, the rate of this decline 
begins to slow down until the valley of the ∆D-response is reached at ~60 min.  The 
response curve maintains this constant response for the next 40 to 50 min.  This period 
(from 30 to 100 min) can be described as a transition state of the ∆D-response.  
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Afterwards, the ∆D-response begins to slowly increase for the next 60 min; this behavior 
can be accredited to cell re-adhesion
270, 326
. 
After pretreating the cells with EGCG overnight, the amplitude of the EGF-
induced ∆D-response curve was suppressed.  The higher the concentration of the EGCG 
used, the greater the reduction of the amplitudes of the EGF-induced ∆D-responses 
(Figure 7.14).  These results indicate that pretreatment of A431 cells with EGCG (50, 70, 
100 µM) for 18 h, resulted in a decreased ∆D-response, thus suggesting that a long 
treatment with EGCG can result in a decreased level of phosphorylated EGFR
413
.     
7.3.6 Inhibition of the EGCG-Induced Time-Dependent Cellular Responses:  
Other inhibitors 
The inhibitory effect of three different compounds was measured as a way to 
understand the relationship between EGCG and the change in cell adhesion.  The three 
drugs used were Blebbistatin, Cytochalasin D and PD158780.  Both Blebbistatin and 
Cytochalasin D are cytoskeletal drugs and PD158780 is a potent inhibitor of EGFR 
tyrosine kinase
325
. 
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Figure 7.15: Real-time quartz crystal microbalance with dissipation monitoring (QCM-D) measurements (overtone n = 
3) of the ∆D-responses of A431 cells to 100 µM EGCG at 37 oC.   The ∆D-responses of the cells were shifted to the 
right by Blebbistatin, a known inhibitor of myosin II ATPase activity, at various doses (0, 5, 10, 20 µM). 
 
   
Figure 7.15 shows the results of the dose-response of the EGCG-induced cellular 
response measured with the QCM-D.  In this experiment, we used Blebbistatin, a small 
molecule inhibitor of nonmuscle myosin IIA
414-415
, which blocks cell blebbing and 
disrupts directed cell migration and cytokinesis in cells.  Blebbistatin has also been 
shown to lower the affinity of myosin with actin, thus altering the contractile forces that 
affect the cytoskeleton-membrane interface
414-416
.       
4 different doses of Blebbistatin (0, 5, 10, 20 µM) were introduced into confluent 
monolayers of A431 cells on QCM-D sensors.  Each inhibitor was incubated at 37 
o
C for 
50 min, after this time, each solution was replaced with a solution of 100 µM EGCG.  
The ∆D-responses at the order of overtone, n = 3, were recorded at 37 oC for 3 h.  In this 
Figure, the ∆D-response curve labeled 0 µM Blebbistatin represents the time-dependent 
profile of A431 cells responding to 100µM EGCG without the presence of the inhibitor.  
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Although, after the addition of the inhibitor, the ∆D-responses shift to the right, but the 
shape of the curves remains similar to the control.   The intensity of the peak that we 
usually observed for EGCG decreases slowly and as the concentration of the EGCG 
increases, this peak appears later, thus suggesting that Blebbistatin slows down the 
EGCG-induced ∆D-response.  Since Blebbistatin inhibits actin-myosin II complexes414-
415
, it could be possible that exposure to this inhibitor might result in a  slight decrease in 
cell rigidity attributed to a decreased acting cytoskeleton stiffness, as it has been 
measured by AFM, optical tweezers and microrheology
417-419
. 
The results of the next experiment are shown in Figure 7.16.  In this experiment 
we investigated the inhibitory effects of Cytochalasin D (CD) on the EGCG-induced ∆D-
response.  Cytochalasin D is a cell permeable inhibitor of actin polymerization, and it is 
capable of weakening the remodeling of the actin filaments
327
.     
 
Figure 7.16:  Real-time quartz crystal microbalance with dissipation monitoring (QCM-D) measurements (overtone n = 
3) of the ∆D-responses of A431 cells to 100 µM EGCG at 37 oC.  The ∆D-responses of the cells were suppressed with 
Cytochalasin D, a known inhibitor of actin polymerization, at various doses (0, 0.3, 1, 4 µM). 
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The ∆D-response curve labeled 0 µM Cytochalasin D represents the time-
dependent profile of A431 cells responding to 100 µM EGCG without the presence of the 
inhibitor.  After the addition of EGCG, the shape of the ∆D-response curve is nearly the 
same for all four experiments, but the intensity of the signal decreases as the 
concentration of the Cytochalasin D increases.  These results indicate that Cytochalasin D 
suppresses the ∆D-response to EGCG, which further emphasizes the connection between 
cytoskeleton remodeling and cell signaling and trafficking
420
. 
The last inhibitor tested was PD158780, which is known to be a potent inhibitor 
of EGFR tyrosine kinase
325
.  This inhibitor was used because the results from our 
previous section suggested that EGCG could block the binding of EGF to EGFR, thus 
preventing autophosphorylation and downstream signal transductions.    
 The ∆D-response curve labeled 0nM PD158780 represents the time-dependent 
profile of A431 cells responding to 100 µM EGCG without the presence of the inhibitor 
(Figure 7.17).  After the addition of EGCG, the ∆D-responses decreased in intensity as 
the concentration of the inhibitor increased.  The shape of the ∆D-response curves is 
relatively similar to that of the control.  These results indicate that lower doses of 
PD158780 (30 and 50 nM) are able to inhibit the EGCG-induced ∆D-response on A431 
cells.  
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Figure 7.17:  Real-time quartz crystal microbalance with dissipation monitoring (QCM-D) measurements (overtone n = 
3) of the ∆D-responses of A431 cells to 100 µM EGCG at 37 oC.  The ∆D-responses of the cells were suppressed with 
PD158780, a known inhibitor of EGFR tyrosine kinase, at various doses (0, 30, 50, 100 nM). 
 
   
The results from each experiment portray particular characteristics of the time-
dependent dose response profiles, as shown in Figures 7.15-7.17.  For example, when the 
cells were exposed to the cytoskeletal modulator, Blebbistatin, the shapes of the curves 
remained the same, but they appeared later as the concentration of the inhibitor increased 
(Figure 7.15).  On the contrary, when the cells were treated with Cytochalasin D, the 
intensity of the ∆D-response diminished as the concentration of the inhibitor increased 
(Figure 7.16).  These results suggest that both cytoskeletal drugs inhibit different 
processes of actin organization.  These specific features of the inhibition profiles can be 
used as a way to investigate mechanistic insights into the regulation of EGCG-induced 
cell adhesion in A431 cells.          
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7.4   Conclusion 
Previous reports have shown EGCG has the ability to produce ROS in cell 
cultures
353, 421-422
.  The current results of this study confirmed this observation when we 
evaluated the EGCG and EGCG-Peracetate-induced cell de-adhesion in A431 cells using 
the QCM-D.  Exposing the A431 cells to EGCG increases the ∆D-response, while 
challenging the cells with EGCG-Peracetate saw the ∆D-response decrease.  The 
differences observed in the ∆D-responses of both compounds could be due to a difference 
in intracellular concentration of EGCG.  To further confirm our findings, we subjected 
the A431 cells to a range of H2O2 concentrations. The results were very similar to those 
obtained using high doses of EGCG-peracetate.  At higher concentrations, the H2O2-
induced response is similar to EGCG-peracetate, where ∆D-response decreases when the 
cells were treated with H2O2.            
The ROS levels induced by EGCG in these cell lines, as measured with the QCM-
D, correlate with both the ROS intracellular measurements and the fluorescence imaging 
results.  By combining these methods, we were able to measure the relationship between 
the ∆D-response and the level of focal adhesions after treatment with EGCG.  This 
relationship indicates that, in this case, the restructuring of focal adhesions are related to 
the formation of ROS after treating the cells with EGCG.      
 In this work, we have used the QCM-D to track the EGCG-induced ROS 
formation using A431 cells.  Based on the results obtained, we can correlate the QCM-D 
response with the change of EGCG-induced ROS formation.  These findings provide us 
with a quantitative tool to follow the EGCG induced ROS formation in real-time with a 
label-free approach.  Overall, these results demonstrate the sensitivity and reliability of 
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the QCM-D as a screening tool, thus showing the potential of this technique to become a 
good sensing platform for ROS screening.   
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Chapter 8: Summary 
Cells communicate with each other and with their environment through signal 
transduction, and this type of cell communication is what allows the cells to convert their 
responses into physiological responses.  Cell adhesion is an important cellular response 
that is due to signal transduction.  There are two types of cell adhesion found in nature, 
cell-cell and cell-substrate adhesion.  In this work, we focused on cell-substrate adhesion 
mediated through receptors known as integrins
35
.  An important function of integrins is to 
regulate signaling cascades initiated by other receptors; among these receptors is EGFR
57-
58
.  Due to the importance of EGFR signaling, any malfunction in the downstream 
signaling pathways can lead to dysregulation of cell growth and may cause the 
development of tumors
291
.  The intracellular downstream signaling pathways that are 
related to cell motility are MAPK/ERK
312
, PI3K
313
 and PLC
123
 pathways.  EGFR 
overexpression has also been linked to enhanced cell motility, which is an important step 
for metastasis and tumor invasion
292-293
.  During cell motility, there is a constant 
alternation of adhesion and de-adhesion, in this process the cell must constantly adjust the 
strength of adhesion to both the ECM and substratum
69
.  Thus, it is possible that 
enhanced cell motility could be caused by the alterations in the capability of the cell to 
restructure its focal adhesions
296
.    
Over the past few decades, acoustic instruments, such as the QCM have been used in 
biological and biomedical research
171, 173-174
.  As stated in chapter 2, the QCM technique 
is a highly sensitive, non-invasive and label-free technique that can be used to monitor 
biological systems.  The usefulness of the QCM in different areas of cell research can be 
attributed to its non-invasive and label-free character, its high sensitivity and excellent 
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time resolution, its ability to simultaneously measure the ∆f and ∆D that allows 
determination of changes in both mass and mechanical properties, its finite sensing depth 
in liquid medium (< 250 nm) and its ease of use
25
.       
The overall objective of this project was to use an acoustic sensor to study the effects 
of the overexpression of EGFR on the ligand-induced restructuring of focal adhesions, to 
examine cell signaling pathways stimulated or inhibited by pharmacological mediation, 
and to develop a method to measure intracellular ROS.   All of these objectives were 
accomplished by taking advantage of the real-time tracking capability of the QCM-D.   
This research is innovative because it integrates acoustic sensors to examine complex 
biological processes, such as cell signaling pathways, cell adhesion and the restructuring 
of focal adhesions.  These studies have provided insights into functional relationships 
between EGFR signaling and cell adhesion.  Based on the results attained, we established 
a technical approach to study the kinetics of cell adhesion in non-cancerous and diseased 
cells due to the specific pharmacological mediation (chapter 5).  Additionally, we 
determined how each specific pathway affects the adhesion of cells (chapter 6).  Finally, 
we established a method that measures intracellular ROS in real-time (chapter 7). This 
integrated approach has provided insights into functional relationships between adhesion 
strength and EGFR overexpression.  This outcome established a quantitative framework 
for the analysis of cell adhesion and functional studies of structural and signaling 
components in physiological processes.  This is important because by using the QCM-D, 
we were able to get kinetic information about the cell adhesion and cell signaling 
pathways, which traditional techniques may not have offered.  
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In chapter 5 we described the EGF-induced restructuring of focal adhesions on 
MCF-10A and MCF-10A-EGFR cells.  We were able to determine that the MCF-10A-
EGFR cells that overexpressed EGFR display a real-time ∆D-response profile very 
different from that of MCF-10A cells, which have a lower level of EGFR compared to 
the with that of the MCF-10A-EGFR cells.  The results showed that after EGF 
stimulation, the MCF-10A-EGFR cells, exhibited an increase in the rate of initial 
disassembly and a decrease in the rate of reassembly of focal adhesions compared to the 
MCF-10A cells. These differences in kinetics indicate that the overexpression of EGFR 
alters the ability of the cells to restructure their focal adhesions, which might lead to 
enhanced cell motility.  Future studies should take into account the biology of the EGFR 
network to a greater extent.  This may improve our understanding of the role that EGFR 
signaling transduction plays in cancer development.        
Chapter 6 demonstrated the QCM-D as a good drug screening platform.  This 
chapter described the results obtained from the pharmacological intervention study 
performed to assess the EGFR signaling pathway in MCF-10A-EGFR cells using the 
QCM-D.  The three well known EGFR downstream signaling pathways, PI3K, 
MAPK/ERK, and PLC pathway, were inhibited by using modulators that target a specific 
signaling protein in each pathway.  The study of these pathways is important because 
they play a role in the mediation of the assembly of focal adhesions and can potentially 
lead to changes in cell adhesion.  To gain more insight on how each pathway affects the 
EGF-induced cell reorganization of focal adhesions, we inhibited each pathway with a 
distinctive modulator.  The inhibition of each pathway generated a particular response 
profile, which we concluded to be an indication that each pathway had a distinctive role 
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in the EGFR signaling process.  In order to corroborate the reliability of the QCM-D as a 
sensing platform for screening drugs, a future study can include the usage of other 
inhibitors that affect the EGFR downstream signaling pathways examined here.  Some of 
the inhibitors that could be used include, wortmannin, PD98059 and Neomycin.  
Wortmannin is an inhibitor of the PI3K signaling pathway
423-424
.  It is considered to be 
more potent than LY294002.  PD98059 inhibits the MAPK/ERK signaling pathway
425-
426
.  Neomycin is an inhibitor of the PLC signaling pathway
427-428
.    
Finally, chapter 7 described a method to track in real-time the production of ROS in 
cell cultures after exposing them to various doses of EGCG.  From the results attained, 
the EGCG-induced ROS formation appeared to be cell-dependent as well as 
concentration-dependent.  Future studies that can be performed as a way to further verify 
that the QCM-D can be used as a tracking tool to measure intracellular ROS, is to test 
other antioxidants on the same cells that were used in this study.  Examples of such 
antioxidants include resveratrol
429-431
 and curcumin
430, 432
, both of which are known for 
their antioxidant and chemopreventive properties.     
In conclusion, the results presented here, demonstrated that the QCM-D is a highly 
sensitive, non-invasive, and label-free technique that has a broad range of applications in 
the fundamental study of cellular processes, such as cell signaling and trafficking and 
mechanotransduction and holds promise to become an effective sensing platform for 
screening therapeutic agents and ROS formation.  This project will provide significant 
information about cell signaling and cell adhesion. Overall, the studies mentioned in this 
work have shown that the QCM-D technique can be used as a method capable of offering 
non-invasive and real-time measurements of cell processes that are vital to the regulation 
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of biological functions.  It may be able to provide enough pharmacological information 
so that testing of drugs on animals can be reduced.    Also, the QCM-D assay might be 
used as a method for personalizing the treatment of a disease; different drugs could be 
tested as specialized treatments on tissue samples from the actual patient.  Finally, the 
QCM-D can be used potentially to test how cells adapt to artificial surfaces (e.g., gold), 
thus giving an insight on the development of material for body implants.   
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APPENDIX 
AI.  Abbreviations 
AFM  Atomic Force Microscopy  
BSA  Bovine Serum Albumin 
D  Dissipation 
DI  Distilled water 
DMEM Dulbecco’s modified Eagle’s medium 
DMEM/F12 Dulbecco’s modified Eagle’s medium: nutrient mix F12 
DS  Dextran Sulfate 
ECIS  Electric Cell-Substrate Impedance Sensing  
ECM  Extra Cellular Matrix 
EDTA  Ethylenediaminetetraacetic acid 
EGCG  Epigallocatechin-3-gallate 
EGCG-P Epigallocatechin-3-gallate peracetate  
EGF  Epidermal Growth Factor 
EGFR  Epidermal Growth Factor Receptor  
EGTA  Ethylene Glycol Tetraacetic Acid 
ERB-B2 Receptor Tyrosine-Protein Kinase 
f  Frequency 
FA  Focal Adhesions 
FADH2 Flavin Adenine Dinucleotide 
FAK  Focal Adhesion kinases 
FBAR  Film Bulk Acoustic Resonator 
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FBS  Fetal Bovine Serum 
FLIC  Fluorescence Interference Contrast Microscopy 
H2O2  Hydrogen Peroxide 
HBSS  Hanks Balanced Salt Solution 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
IDT  Internal Digital Transducer 
MAPK  Mitogen Activated Protein Kinase 
MgCl2  Magnesium Chloride 
NADH  Nicotinamide Adenine Dinucleotide 
PBS  Phosphate Saline Buffer 
PFA  Paraformaldehyde 
PI3K  Phosphoinositide 3-Kinase 
PIP2  Phosphoinositol 4,5-bisphosphate 
PIPES  Piperazine-N,N’-bis(2-ethanesulfonic acid)  
PLCγ  Phospholipase C Gamma 
PLL  Polyelectrolytes poly(L-lysine) 
QCM  Quartz Crystal Microbalance 
QCM-D Quartz Crystal Microbalance with Dissipation 
Q-Factor Quality Factor 
REDOX Oxidation-Reduction Reactions 
RICM  Reclection Interference Contrast Microscopy 
ROS  Reactive Oxygen Species 
RTK  Receptor Tyrosine Kinases 
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SAW  Surface acoustic waves 
SDS  Sodium Dodecyl Sulfate 
SEM  Scanning Electron Microscopy 
SFM  Scanning Force Microscopy 
SiO2  Silicon Dioxide 
SLBs  Supported Lipid bilayers 
SPR  Surface Plasmon Resonance 
TIRF  Total Internal Reflection fluorescence Microscopy 
TM  Transmembrane 
VEGFR Vascular Endothelial Growth Factor Receptor 
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Appendix A.2.  Real-time QCM-D measurements (at the order of overtone n=3) of the 
∆D-response of A431 cells at 37oC.  Side-by side comparison of the ∆D-response of 
A431 cells seeded on two different sensors, glass and gold after 100µM EGCG 
stimulation.   
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